cytarabine has been researched along with Neoplasms in 304 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 180 (59.21) | 18.7374 |
| 1990's | 42 (13.82) | 18.2507 |
| 2000's | 32 (10.53) | 29.6817 |
| 2010's | 37 (12.17) | 24.3611 |
| 2020's | 13 (4.28) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, C; Köttgen, E; Reutter, W | 1 |
| Asao, T; Izawa, H; Matta, KL; Miyamoto, Y; Yazawa, S | 1 |
| Matsuda, A; Sasaki, T; Takenuki, K; Ueda, T | 1 |
| Huang, F; Kuo, RY; Lee, KH; Morris-Natschke, S; Peng, S; Qian, K; Wang, C; Zhang, X; Zhao, M | 1 |
| Kamiie, K; Kidachi, Y; Noshita, T; Ryoyama, K; Umetsu, H; Yamaguchi, H; Yu, T | 1 |
| Li, C; Peng, S; Wang, W; Wang, Y; Wu, J; Zhao, M | 1 |
| Baraniak, D; Celewicz, L; Kacprzak, K | 1 |
| Beck, WT; Bleeker, NP; Das, SG; Doshi, JM; Hermanson, DL; Srinivasan, B; Tang, R; Xing, C | 1 |
| Chandra, G; Chang, TS; Choi, S; Jang, JY; Jeong, LS; Kim, G; Lee, SK; Lee, Y; Moon, YW; Mulamoottil, VA; Nayak, A; Noh, M; Oh, K; Sahu, PK; Song, J | 1 |
| Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
| Celewicz, L; Chojnacka, K; Hoffmann, M; Kacprzak, K; Kleczewska, N; Lewandowska, M; Ruszkowski, P | 1 |
| Chen, Y; Guo, H; Jin, J; Jin, Q; Li, B; Li, T; Lin, G; Ling, J; Lu, S; Lu, T; Wang, Y; Wang, Z; Yang, T; Yao, C; Yuan, H; Zhang, L; Zhi, Y | 1 |
| Duan, L; Hu, L; Li, W; Liao, G; Liu, Z; Ma, L; Wu, P; Yang, D; Zeng, L | 1 |
| Chen, W; Chen, X; Guo, X; Jiang, Z; Li, D; Long, G; Wang, X; You, Q | 1 |
| Ding, N; Gao, W; He, B; He, K; Huang, C; Li, L; Liu, R; Lu, S; Luo, M; Nice, EC; Peng, P; Tian, H; Wang, D; Wang, Y; Wu, P; Xie, N; Yang, M; Zhang, Z | 1 |
| Chen, K; Dong, L; He, H; Jiang, T; Pan, Z; Pang, X; Song, Y; Wang, M; Yang, G; Ye, X; Zhou, T | 1 |
| Jin, L; Li, Y; Liu, X; Lu, L; Qu, J; Xiao, M; Xu, L; Yin, Z | 1 |
| Bauermeister, A; Branco, PC; Costa-Lotufo, LV; Gaudêncio, SP; Jimenez, PC; Rezende-Teixeira, P; Wilke, DV | 1 |
| Cho, WC; Kobarfard, F; Kumar, P; Martins, N; Martorell, M; Pezzani, R; Rajabi, S; Redaelli, M; S Mileski, K; Salehi, B; Selamoglu, Z; Sharifi-Rad, J; Subhra Santra, T | 1 |
| Barcinska, E; Inkielewicz-Stepniak, I; Sobczak, K; Steckiewicz, KP; Tomczyk, E; Wojcik, M | 1 |
| Dorn, J; Drecoll, E; Frejno, M; Heinzlmeir, S; Helm, D; Hogrebe, A; Kleigrewe, K; Kuster, B; Kvasnicka, HM; Meng, C; Mergner, J; Oellerich, T; Ruprecht, B; Samaras, P; Scheich, S; Serve, H; Weichert, W; Wilhelm, M; Zecha, J | 1 |
| Beijnen, JH; Derissen, EJB | 1 |
| Chilaka, NK; Namoju, R | 1 |
| Bush, R; Buxton, A; Constine, LS; Friedman, DL; Giulino-Roth, L; Kelly, KM; Pei, Q; Schwartz, CL; Wolden, SL; Wu, Y | 1 |
| Agostini, LC; Brody, JR; Gmeiner, WH; Golan, T; Haber, AO; Jain, A; Mani, C; Nevler, A; Palle, K; Yeo, CJ | 1 |
| Allis, CD; Chen, H; Chen, X; Lu, C; Majewski, J; Rajagopalan, KN; Weinberg, DN | 1 |
| Akhtar, N; Britton, D; Casado, P; Cutillas, PR; Dokal, A; Fitzgibbon, J; Gerdes, H; Hijazi, M; Khorsandi, S; Osuntola, R; Rajeeve, V; Travers, J | 1 |
| Bosch, M; Danyluk, P; Dusyk, T; Elemary, M; Hahn, L; Lim, H; Sabry, W; Stakiw, J | 1 |
| Armbruster, M; Brandlhuber, M; Braun, FM; Ertl-Wagner, B; Holzner, V; Meinel, FG; Sommer, WH | 1 |
| Eshima, K; Fukushima, M; Iizuka, K; Jin, C; Zhang, C | 1 |
| Bertrand, A; Cervos, M; Devaux, Y; Favier, B; Goy, F; Marcault-Derouard, A; Schell, M; Veyet, V | 1 |
| Costa-Lotufo, LV; Jimenez, PC; Wilke, DV | 1 |
| Hu, X; Jiang, W; Jiang, Y; Jin, G; Liu, R; Luan, Y; Wu, J | 1 |
| Brendle, C; la Fougère, C; Nikolaou, K; Pfannenberg, C; Ripkens, S; Soekler, M; Stef, I; Stefan, N | 1 |
| Louie, AC; Mayer, LD; Tardi, P | 1 |
| Aramendía, JM; Carranza, OE; Castañón, E; Espinós, J; Fusco, JP; Gil-Bazo, I; Martín, P; Rodríguez, J; Santisteban, M; Zubiri, L | 1 |
| Ashworth, MT; Daud, AI; Freshwater, T; Goldman, JW; Grabowsky, JA; Isaacs, R; Kang, SP; Loechner, S; Mendelson, D; Munster, PN; Parry, D; Rosen, LS; Shanahan, F; Shumway, S; Sorge, C; Springett, G; Strosberg, J; Venook, AP | 1 |
| Behlendorf, T; Globig, C; Jahn, F; Jordan, B; Jordan, K; Müller-Tidow, C; Schmoll, HJ | 1 |
| Terui, Y | 1 |
| Cragg, GM; Pezzuto, JM | 1 |
| Bohannan, Z; Borthakur, G; Bueso-Ramos, C; Daver, N; Faderl, S; Garcia-Manero, G; Hosing, C; Jabbour, E; Kadia, T; Kantarjian, HM; Khoury, JD; Maduike, R; Miller, D; Patel, K; Pemmaraju, N; Ravandi, F; Sasaki, K; Verstovsek, S | 1 |
| Balaban, NQ; Gefen, O; Pearl Mizrahi, S; Simon, I | 1 |
| Bąk, A; Dybał, P; Jampilek, J; Kozik, V; Pentak, D; Sochanik, A | 1 |
| Bajwa, RPS; Gerhardt, CA; Hagedoorn, M; Keim, MC; Lehmann, V; Olshefski, RS; Tuinman, MA; Winning, AM | 1 |
| Iranshahi, M; Nasseri, MA; Taleghani, A | 1 |
| Banerji, U; Fancourt, C; Hirsch, H; Hong, DS; Johnson-Levonas, AO; Knox, CD; Lam, R; Mahipal, A; Meister, AK; Rose, S; Russo, G; Somaiah, N; Wagner, AJ | 1 |
| Aamdal, S; Dueland, S; Gaullier, JM; Lind, MJ; Rasch, W; Sandvold, ML; Thomas, H | 1 |
| Amo, H; Ariyoshi, Y; Hoshino, A; Imai, K; Kamei, Y; Kataoka, K; Kato, T; Kurita, S; Murakami, M; Nishimura, M; Ogawa, M; Ota, K; Oyama, A | 1 |
| Arpaci, F; Ataergin, S; Kilic, S; Komurcu, S; Kuzhan, O; Ozet, A; Ozturk, B; Ozturk, M | 1 |
| Fridley, BL; Jenkins, GD; Kalari, KR; Li, L; Lingle, W; Lou, Z; Pei, H; Petersen, G; Wang, L | 1 |
| Batzler, A; Fridley, BL; Jenkins, G; Kalari, K; Li, L; Wang, L; Weinshilboum, RM | 1 |
| Chamberlain, MC; Fisher, R; Glantz, MJ; Van Horn, A | 1 |
| Bauerschmitz, GJ; Cerullo, V; Diaconu, I; Escutenaire, S; Hemminki, A; Hernandez-Alcoceba, R; Kanerva, A; Pesonen, S | 1 |
| Aguiar, Sdos S; Brandalise, SR; de Azevedo, AC; Pinheiro, VR; Rizzatti, M | 1 |
| Andrassy, RJ; Kulkarni, AD; Moore-Olufemi, SD; Shah, SK; Sundaresan, A; Walker, PA | 1 |
| Bartal, A; Liszkay, G; Mátrai, Z; Szûcs, A | 1 |
| Chamberlain, MC | 1 |
| Braess, J; Holdenrieder, S; Kolligs, FT; Manukyan, D; Stieber, P | 1 |
| Ashworth, A; Cunningham, D; Elliott, R; Hewish, M; Lord, CJ; Martin, SA | 1 |
| Hamada, A; Kawaguchi, T; Nakano, M | 1 |
| Bessho, A; Fujii, N; Harada, M; Hiramatsu, Y; Ikeda, K; Imai, T; Ishimaru, F; Koide, N; Kojima, K; Kozuka, T; Maeda, Y; Matsuo, K; Niiya, K; Noguchi, T; Shinagawa, K; Sunami, K; Takenaka, K; Tanimoto, M; Teshima, T; Yamamoto, K | 1 |
| Casimir, L; Lopardo, H; Luppino, V; Paganini, H; Staffolani, V; Zubizarreta, P | 1 |
| Chamberlain, MC; Cole, BF; Glantz, MJ; Jaeckle, KA; Mackowiak, JI | 1 |
| BOSTWICK, L; EVANS, JS; MENGEL, GD | 1 |
| EVANS, JS; MENGEL, GD | 1 |
| BOSTWICK, L; EVANS, JS; MENGEL, GD; MUSSER, EA | 1 |
| KITAHARA, T; MELNICK, JL; RAPP, F | 1 |
| CHU, MY; FISCHER, GA | 1 |
| Bloomfield, CD; Byrd, JC; Carroll, AJ; Edwards, CG; Kolitz, JE; Larson, RA; Marcucci, G; Mayer, RJ; Moore, JO; Mrózek, K; Pettenati, MJ; Ruppert, AS; Stamberg, J; Sterling, LJ; Vardiman, JW | 1 |
| Armstrong, TS; Gilbert, MR | 1 |
| Ikarashi, Y; Imai, C; Kakihara, T; Tanaka, A; Uchiyama, M; Watanabe, A | 1 |
| Hori, H; Kawasaki, H; Komada, Y; Miyahara, M; Ogawa, M; Ohta, T; Taniguchi, N | 1 |
| Broekhuizen, AJ; Creutzig, U; Gibson, B; Hubeek, I; Kaspers, GJ; Peters, GJ; Schouten van Meeteren, AY; Talianidis, I; van Wering, ER | 1 |
| Cooper, T; Gandhi, V; Kantarjian, H; Plunkett, W | 1 |
| Bergman, AM; Hendriks, HR; Kuiper, CM; Myhren, F; Peters, GJ; Sandvold, ML | 1 |
| Schott, H; Schwendener, R | 1 |
| Abd El-Hady, D; Abo El-Maali, N; Andrisano, V; Gotti, R | 1 |
| Ballmer-Hofer, K; Langer-Machova, Z; Marty, C; Schott, H; Schwendener, RA; Sigrist, S | 1 |
| Beyer, U; Gnad-Vogt, SU; Hochhaus, A; Hofheinz, RD | 1 |
| Brambilla, G; Castagna, L; Magagnoli, M; Masci, G; Morenghi, E; Pedicini, V; Poretti, D; Santoro, A | 1 |
| Bally, MB; Harasym, NL; Harasym, TO; Janoff, AS; Johnstone, SA; Mayer, LD; Ramsay, EC; Shew, CR; Tardi, PG | 1 |
| Gojkovic, Z; Hasholt, L; Joergensen, T; Knecht, W; Le Breton, C; Munch-Petersen, B; Piskur, J; Rozpedowska, E; Sandrini, MP; Willer, M | 1 |
| Benhadji, K; Calvo, F; Chiao, J; Cvitkovic, E; Faivre, S; Galmarini, CM; Ghoul, A; Green, SR; Le Tourneau, C; Raymond, E; Serova, M | 1 |
| Hersh, EM; Oppenheim, JJ | 1 |
| Ellims, PH | 1 |
| Chabner, BA; Clendeninn, NJ; Curt, GA | 1 |
| Imamishi, J; Tanaka, A | 1 |
| Markman, M | 4 |
| Clarkson, AR; Healy, HG | 1 |
| Ghavimi, F; Miller, DR; Rosen, G; Steinherz, PG; Wang, Y; Wollner, N | 1 |
| Eyring, H; Miles, DL; Miles, DW | 1 |
| Armstrong, D; Fox, JJ; Leyland-Jones, B; Lopez, C; Philips, FS; Schneider, R; Tan, CT; Watanabe, KA; Young, CW | 1 |
| Burke, PJ; Karp, JE; Vaughan, WP | 1 |
| Allegra, CJ; Chabner, BA; Curt, GA; Fine, RL; Yeh, GW | 1 |
| Hill, DL; Montgomery, JA | 1 |
| Dozi-Vassiliades, J; Hatzitheodoridou, P; Kourakis, A; Mourelatos, D; Tsiouris, J | 1 |
| Baguley, BC; Finlay, GJ | 1 |
| Muscato, JJ; Muscato, MS; Perry, MC; Schilsky, RL | 1 |
| Leyva, A; Pinedo, HM; Schornagel, JH | 1 |
| Kato, Y; Kawashima, K; Morishima, Y; Ohno, R; Tanimoto, M; Yamada, K | 1 |
| Fujita, M; Hayata, S; Taguchi, T | 1 |
| Tschiersch, B | 1 |
| Cheng, YC; Dutschman, G; Ruth, JL; Tan, RS | 1 |
| Arkin, H; Holland, JF; Ohnuma, T | 1 |
| Martin, DS; Nayak, R; Sawyer, RC; Spiegelman, S; Stolfi, RL; Woodcock, T; Young, CW | 1 |
| David, R; Duhamel, G; Gorin, NC; Najman, A; Parlier, Y; Petit, JC; Salmon, C; Stachowiak, J | 1 |
| Au, JL; Danhauser, L; Luccioni, C; Rustum, YM | 1 |
| Amaki, I; Hattori, K; Hirota, Y; Hoshino, A; Ichimaru, M; Ito, M; Kimura, I; Kimura, K; Maekawa, T; Masaoka, T; Nakamura, T; Ogawa, M; Oguro, M; Ohta, K; Osamura, S; Sakai, Y; Shimoyama, M; Takaku, F; Uzuka, Y; Yamada, K | 1 |
| Frindel, E; Guigon, M | 1 |
| Desaive, C; Grattarola, M; Nicolini, C; Zietz, S | 1 |
| Cubitt, S; Enns, L; Hirani-Hojatti, S; Karimian, K; Mirzayans, R; Murthy, K; Paterson, MC; Radatus, B | 1 |
| Dercksen, MW; Dirkson, MK; Gerritsen, WR; Pinedo, HM; Rodenhuis, S; Schaasberg, WP; Slaper-Cortenbach, IC; van der Schoot, CE; von dem Borne, AE | 1 |
| Matsuda, A | 2 |
| Bout, M; Brémond, JL; Dayan, A; Delain, M; Domenech, J; Gihana, E; Linassier, C; Petit, A; Petitdidier, C; Truglio, D | 1 |
| Abe, T; Kawano, Y; Makimoto, A; Nakagawa, R; Okamoto, Y; Saito, S; Sato, J; Shimizu, T; Suzue, T; Takaue, Y | 1 |
| Mehta, J; Philpott, N; Powles, R; Treleaven, J | 1 |
| Peters, GJ; Ruiz van Haperen, VW | 1 |
| Crist, WM; Pratt, CB; Pui, CH; Rivera, GK; Santana, VM | 1 |
| Milano, GA; Peters, GJ; Schornagel, JH | 1 |
| Parshad, R; Price, FM; Sanford, KK; Schapiro, MB; Tarone, RE | 1 |
| Cates, C; Chamberlain, MC; Chatelut, E; Howell, SB; Kim, JC; Kim, S; Kormanik, PA | 1 |
| Aalberg, V; Komulainen, J; Rautonen, J; Ropponen, P; Siimes, MA | 1 |
| Nakamura, T; Ueda, T | 1 |
| Bianco, AR; Caraglia, M; Correale, P; Del Vecchio, S; Esposito, G; Genua, G; Pinto, A; Tagliaferri, P | 1 |
| Ager, S; Baglin, TP; Barker, P; Bass, G; Bloxham, DM; Boraks, PA; Hood, IM; Jestice, HK; Johnson, D; Mahendra, P; Marcus, RE; Scott, MA | 1 |
| Gaarsdal, E; Jensen, L; Johnsen, HE; Knudsen, LM; Nielsen, KJ; Nikolaisen, K | 1 |
| Balasubramanian, M; Buckingham, LE; Coon, JS; Emanuele, RM; Komarov, PG; Piraner, O; Roninson, IB; Shtil, AA | 1 |
| Damon, LE; Linker, CA; Ries, CA; Rugo, HS; Smith, GA | 1 |
| Bessho, A; Harada, M; Higuchi, M; Miyamoto, T; Miyoshi, T; Ohno, Y; Omoto, E; Shinagawa, K; Sunami, K; Teshima, T; Ueoka, H | 1 |
| Devereux, S; Goldstone, AH; Leverett, D; Linch, DC; Peniket, AJ; Perry, AR; Sullivan, AM; Watts, MJ; Williams, CD | 1 |
| Blumenstengel, K; Fricke, HJ; Höffken, K; Kath, R; Kunert, C; Sayer, HG; Vogel, W | 1 |
| Matsuda, A; Sasaki, T | 1 |
| Grant, S; Jarvis, WD | 1 |
| Lennard, L | 1 |
| Chamberlain, MC; Cole, BF; Glantz, MJ; Howell, SB; Jaeckle, KA; LaFollette, S; Maria, B; Phuphanich, S; Recht, L; Schumann, GB; Swinnen, LJ | 1 |
| Eguchi, H; Ogawa, K; Tachibana, K; Tamura, K; Uchida, T; Yamashita, N | 1 |
| Barişta, I | 1 |
| Akutsu, M; Furukawa, Y; Honma, Y; Kano, Y; Mano, H; Sato, Y; Tsunoda, S | 1 |
| Johansson, M; Karlsson, A; Sanda, A; Zhu, C | 1 |
| Choe, YH; Conover, CD; Greenwald, RB; Royzen, M; Wu, D | 1 |
| Herrera, P; Jodra, MH; Laraña, JG; López, J; Navarro, JL; Odriozola, J; Pérez de Oteyza, J; Ramos, ML; Ramos, P; Roldán, E; Villalón, L; Zamora, C | 1 |
| Al-Khaldi, A; Beauséjour, CM; Eliopoulos, N; Galipeau, J; Momparler, LF; Momparler, RL | 1 |
| Brant, J; Nielsen, E | 1 |
| Chabner, BA; Coleman, CN; Johns, DG; Myers, CE | 1 |
| Salem, PA | 1 |
| Frei, E; Krishan, A; Paika, KD; Pitman, SW; Smith, DC; Tattersall, HN | 1 |
| Chabner, BA; Myers, CE; Oliverio, VT | 1 |
| Alberto, P; Brugarolas, A; Cavalli, F; Gangji, D; Hansen, HH; Rozencweig, M; Siegenthaler, P; Sylvester, R | 1 |
| Conn, H; Folkman, J; Langer, RS; Tapper, D | 1 |
| Finklestein, JZ; Hammond, D; Higgins, G; Krivit, W | 1 |
| Le Pecq, JB | 1 |
| Calabresi, P; Cummings, FJ; Hoovis, ML | 1 |
| Betts, RF; Douglas, RG; Royer, G; Zaky, DA | 1 |
| Glomstein, A; Lie, KK; Lie, SO | 1 |
| Haskell, CM | 1 |
| Grindey, GB; Mihich, E | 1 |
| Alberto, P | 1 |
| Sweet, DL; Ultmann, JE | 1 |
| Belousova, AK | 1 |
| Double, JA; Workman, P | 1 |
| Cavalier, J; David, R; Duhamel, G; Gorin, NC; Hirsch Marie, F; Jullien, AM; Leblanc, G; Muller, JY; Najman, A; Parlier, Y; Petit, JC; Salmon, C; Stachowiak, J | 1 |
| Cheng, YC; Creaven, P; Mihich, E; Pavelic, Z; Rustum, Y | 1 |
| Burchenal, JH; Currie, VE; Krakoff, IH; Mackey, RW; Tan, CT; Wong, PP; Young, CW | 1 |
| Chabner, BA; Drake, JC; Hande, KR | 1 |
| Balcerska, A; Janikowska-Lasek, A | 1 |
| Valeriote, FA | 1 |
| Peter, HJ; Sauter, C; Stahel, RA | 1 |
| Kim, M; Perry, S; Woo, KB | 1 |
| Gordon, CS; Krakoff, IH; Kreis, W; Woodcock, TM | 1 |
| Bernstein, IL | 1 |
| Calabresi, P; Heppner, GH | 1 |
| Goetz, O | 1 |
| DePhilip, RM; Lieberman, I; Lynch, WE | 1 |
| Ho, DH; Neil, GL | 1 |
| Kent, S | 1 |
| Gross, R; Hirschmann, WD | 1 |
| Bodey, GP; Freireich, EM; McCredie, KB; Whitecar, JP | 1 |
| Nicolini, C | 1 |
| Gailani, S; Nussbaum, A | 1 |
| Bertino, JR | 1 |
| Armstrong, DM; Aust, JB; Cruz, AB; Dowell, KE | 1 |
| Curby, WA; Rosenoer, VM | 1 |
| Bodey, GP; Freireich, EJ; Loo, TL; Rodriguez, DH | 1 |
| Folkman, J; Johnson, R; Tapper, D | 1 |
| Hattori, T; Nimoto, M; Tohge, T; Yamagata, S | 1 |
| Canty, A; Dyson, PG; Haylock, DN; Juttner, CA; Thorp, D; To, LB | 1 |
| Abe, T; Hirao, A; Koyama, T; Okamoto, Y; Saito, S; Sato, J; Shimizu, T; Suzue, T; Takaue, Y; Watanabe, T | 1 |
| Weiss, RB | 1 |
| Chen, AP; Grem, JL | 1 |
| Carlsson, J; Daniel-Szolgay, E; Erlanson, M | 1 |
| Cersosimo, RJ | 1 |
| Parshad, R; Price, FM; Sanford, KK; Tarone, RE | 1 |
| Allegra, CJ; Chabner, BA; Chu, E; Grem, JL; Johnson, P; Yeh, GC | 1 |
| Chang, EH; Cunningham, JM; Francis, GE; Holland, MJ; Pirollo, KF | 1 |
| Arita, M; Fujii, A; Matsuda, A; Okumoto, T; Sakata, S; Sasaki, T; Ueda, T; Yamagami, K | 1 |
| Fields, SM; Koeller, JM | 1 |
| Dmitrovsky, E; Markman, M; Marks, PA | 1 |
| Alvarado, C; Camitta, B; Fernbach, DJ; Krischer, J; Mahoney, DH; Tebbi, CK | 1 |
| Albain, KS; Erickson, LC; Fisher, RI; Stiff, PJ; Swinnen, LJ | 1 |
| Altman, AJ; Johnson, GM; Quinn, JJ; Scoopo, FJ; Weisman, SJ | 1 |
| Carde, P; Ganem, G; Gouyette, A | 1 |
| Moriconi, WJ; Slavik, M; Taylor, S | 1 |
| Durr, FE; Lindh, D; Wallace, RE | 1 |
| Bregni, M; Gianni, AM; Siena, S; Tarella, C | 1 |
| Ota, K | 2 |
| Bleyer, WA | 1 |
| Capizzi, RL; Jackson, DV; Muss, HB; Powell, BL; Richards, F; Smith, WJ; White, DR; Zekan, PJ | 1 |
| Capizzi, RL | 1 |
| Anai, H; Kusumoto, H; Kusumoto, T; Maehara, Y; Sugimachi, K | 1 |
| Gray, RG; Hayhoe, FG; Rees, JK; Swirsky, D | 1 |
| Saneyoshi, M | 1 |
| Berger, MR; Schmähl, D | 1 |
| Pályi, I | 1 |
| Hoth, DF; King, SA; Leyland-Jones, B; O'Dwyer, PJ | 1 |
| Harrison, P | 1 |
| Beisker, W; Dolbeare, F; Gray, JW; Pallavicini, MG; Waldman, F | 1 |
| Appelbaum, FR; Buckner, CD | 1 |
| Lampkin, BC; Wong, KY | 1 |
| Donnelly, H; Donner, AL; Fanucchi, M; Fox, J; Groshen, S; Leyland-Jones, B; Myskowski, P | 1 |
| Izumi, T; Kamano, T; Satou, H; Yoshida, M | 1 |
| Cheson, BD; Chun, HG; Friedman, MA; Jasperse, DM | 1 |
| Burzynski, SR; Lee, SS | 1 |
| Hattori, K; Hirano, M; Hoshino, A; Ito, M; Kimura, K; Maekawa, T; Miura, Y; Nakamura, T; Ohno, R; Ota, K | 1 |
| Bartolucci, R; Brugia, M; Buzzi, F; Di Costanzo, F; Maragoni, M; Padalino, D; Proietti, MG | 1 |
| Wakui, A | 1 |
| Takaku, F | 1 |
| Bertram, JH; Terman, DS | 1 |
| Kamiya, H; Kawasaki, H; Nobori, T; Sakurai, M | 1 |
| Bloomfield, CD; Duane, SF; Hurd, DD; Michels, SD; Peterson, BA | 1 |
| Kufe, DW; Robbins, G; Spriggs, DR; Takvorian, T | 1 |
| Atkins, JN; Capizzi, RL; Cooper, MR; Craig, J; Ferree, D; Homesley, HD; Jobson, V; McMahan, RA; Muss, HB; Powell, BL | 1 |
| Anderson, J; Green, MR; Schilsky, RL | 1 |
| Bergevin, PR; Blom, J; Tormey, DC | 1 |
| Greenwald, ES | 1 |
| Frei, E | 1 |
| Mott, MG | 1 |
| Goerttler, K; Kaufmann, M; Mattern, J; Volm, M; Wayss, K | 1 |
| Simmonds, WP | 1 |
| Lichter, W; Lopez, DM; Sigel, MM | 1 |
| Brockman, RW | 1 |
| Mattern, J; Volm, M; Wayss, K | 1 |
| Abendroth, K; Siering, VH | 1 |
| Gray, GD | 1 |
| Bodey, GP; Goldschmidt, MC | 1 |
| Mellett, LB | 1 |
| Calabresi, P | 1 |
| Anken, M; De Torres, RA; Dubbs, DR; Kit, S; Kitahara, T; Melnick, JL | 1 |
| Bergsagel, DE | 1 |
| Guibout, P; Hamel, C; Israel, L; Kreis, B | 1 |
| Coltman, CA; Davis, CM; VanDersarl, JV | 1 |
| Feldman, S; Hughes, WT; Kim, HY | 1 |
| Skipper, HE | 1 |
| Fortner, CL; Greene, WH; Schimpff, SC; Wiernik, PH | 1 |
| Praga, C | 1 |
| Cabiness, JR; Shullenberger, CC; Sinkovics, JG | 1 |
| Baker, DH; Berdon, WE; Renert, WA | 1 |
| Mathe, G; Pouillart, P; Schwarzenberg, L | 1 |
| Clarkson, B; Erichson, R; Finch, S; Flannery, J; Grann, V | 1 |
| Azarnoff, DL; Hoogstraten, B; Huffman, DH; Larsen, WE; Wan, SH | 1 |
| Crowther, D | 1 |
| Conroy, JF | 1 |
| Tattersall, MH | 1 |
| Goldin, A | 2 |
| Cardoso, SS; Good, RA; Halberg, F; Haus, E; Kühl, JF; Lee, JK; Pauly, JE; Rosene, G; Runge, W; Scheving, LE; Shiotsuka, R; Spalding, JF | 1 |
| Hall, TC | 1 |
| Hattori, T | 1 |
| Gutterman, JU; Hersh, EM; Mavligit, GM; Reed, RC | 1 |
| Kreis, W; Wechter, WJ | 1 |
| Cohen, SM; Greenspan, EM; Weiner, MJ | 1 |
| Braine, H; Colvin, M; Davis, PJ; DeFronzo, RA | 1 |
| Armata, J; Cyklis, R; Legutko, L | 1 |
| Cooper, EH | 1 |
| Berndt, H; Rieche, K | 1 |
| Dayton, PG; Kinkade, JM; Vogler, WR | 1 |
| Burke, PJ; Carbone, PP; Serpick, AA; Tarr, N | 1 |
| Brunner, KW | 1 |
| Bertino, JR; Calabresi, P; DeConti, RC; Mitchell, MS; Wade, ME | 1 |
| Creasey, WA; Sartorelli, AC | 1 |
| Cohen, SS | 1 |
| Vogler, WR | 1 |
| Wilmanns, W | 1 |
| Frei, E; Goldin, A; Henderson, ES; Holland, JF; Newman, JW; Sandberg, JS | 1 |
| Gilden, RV; Huebner, RJ; Kern, J; Lee, YK; Lennette, EH; Melnick, JL; Rapp, F; Rapp, HJ; Riggs, JL; Turner, HC; Zbar, B | 1 |
| Carter, SK; Livingston, RB | 1 |
| Lamerton, LF | 1 |
| Humphrey, EW; Kinne, DW | 1 |
| Furue, H; Furukawa, K; Harashima, S; Kanko, T; Nakao, I | 1 |
| Hermanský, F | 1 |
| Goldie, JH; Price, LA | 1 |
| Bell, WR; Block, JB; Brecher, G; Carbone, PP; Whang, JJ | 1 |
| Aoki, Y; Moore, GE | 1 |
| Bagshawe, KD | 1 |
| Rall, DP | 1 |
| Brodovsky, HS; Burke, PJ; Colsky, J; Edmonson, JH; Hall, TC; Owens, AH; Schilling, A; Shnider, BI; Wallace, HJ | 1 |
| Falkson, G; Falkson, HC; van Eden, EB | 1 |
71 review(s) available for cytarabine and Neoplasms
| Article | Year |
|---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
The development of piperidinones as potent MDM2-P53 protein-protein interaction inhibitors for cancer therapy.
Topics: Dose-Response Relationship, Drug; Humans; Ligands; Molecular Structure; Neoplasms; Piperidones; Protein Binding; Proto-Oncogene Proteins c-mdm2; Structure-Activity Relationship; Tumor Suppressor Protein p53 | 2018 |
Enriching cancer pharmacology with drugs of marine origin.
Topics: Animals; Antineoplastic Agents; Biological Products; Clinical Trials as Topic; Cytarabine; Drug Discovery; Furans; Humans; Ketones; Neoplasms; Porifera; Trabectedin | 2020 |
Liposomal Cytarabine as Cancer Therapy: From Chemistry to Medicine.
Topics: Animals; Antineoplastic Agents; Cytarabine; Drug Compounding; Humans; Liposomes; Neoplasms | 2019 |
Intracellular Pharmacokinetics of Pyrimidine Analogues used in Oncology and the Correlation with Drug Action.
Topics: Cytarabine; Deoxycytidine; Fluorouracil; Gemcitabine; Humans; Neoplasms; Phosphorylation; Prodrugs; Pyrimidines | 2020 |
Marine drugs for cancer: surfacing biotechnological innovations from the oceans.
Topics: Antineoplastic Agents; Aquatic Organisms; Biotechnology; Brentuximab Vedotin; Cytarabine; Drug Development; Drug Discovery; Furans; Immunoconjugates; Ketones; Neoplasms; Oceans and Seas; Trabectedin | 2018 |
CPX-351: a nanoscale liposomal co-formulation of daunorubicin and cytarabine with unique biodistribution and tumor cell uptake properties.
Topics: Cytarabine; Daunorubicin; Drug Compounding; Endocytosis; Humans; Liposomes; Neoplasms; Tissue Distribution | 2019 |
Natural Products as a Vital Source for the Discovery of Cancer Chemotherapeutic and Chemopreventive Agents.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Biological Products; Cancer Vaccines; Chemoprevention; Cytarabine; Dietary Supplements; Humans; Neoplasms; Phytochemicals; Resveratrol; Stilbenes | 2016 |
An evidence-based review of a Lentinula edodes mushroom extract as complementary therapy in the surgical oncology patient.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bacterial Infections; Biological Products; China; Cisplatin; Cytarabine; Dexamethasone; Evidence-Based Medicine; Humans; Immunosuppression Therapy; Japan; Neoplasms; Polysaccharides; Randomized Controlled Trials as Topic; Shiitake Mushrooms; Tegafur; United States; Uracil; Virus Diseases | 2011 |
[Main treatment and preventive measures for hand-foot syndrome, a dermatologic side effect of cancer therapy].
Topics: Antineoplastic Agents; Capecitabine; Cytarabine; Deoxycytidine; Docetaxel; Doxorubicin; Fluorouracil; Foot Dermatoses; Hand Dermatoses; Humans; Neoplasms; Peripheral Nervous System; Quality of Life; Severity of Illness Index; Skin; Syndrome; Taxoids | 2011 |
Clinical pharmacokinetics of cytarabine formulations.
Topics: Animals; Antimetabolites, Antineoplastic; Area Under Curve; Chemistry, Pharmaceutical; Cytarabine; Delayed-Action Preparations; Emulsions; Half-Life; Humans; Liposomes; Metabolic Clearance Rate; Neoplasms | 2002 |
Liposomal encapsulated anti-cancer drugs.
Topics: Animals; Anthracyclines; Antineoplastic Agents; Camptothecin; Cardiomyopathies; Clinical Trials as Topic; Cytarabine; Humans; Liposomes; Neoplasms; Platinum Compounds; Vincristine | 2005 |
Thymidine as an anticancer agent, alone or in combination. A biochemical appraisal.
Topics: Animals; Antineoplastic Agents; Azacitidine; Cytarabine; Decitabine; Drug Therapy, Combination; Fluorouracil; Humans; Methotrexate; Neoplasms; Thymidine | 1982 |
Selective uptake and retention of anticancer agents by sensitive cells.
Topics: Animals; Antineoplastic Agents; Cytarabine; Doxorubicin; Floxuridine; Fluorouracil; Humans; Melphalan; Methotrexate; Neoplasms | 1980 |
Is there a role for thymidine in cancer chemotherapy?
Topics: Cytarabine; Drug Therapy, Combination; Fluorouracil; Humans; Kinetics; Leukemia; Methotrexate; Neoplasms; Thymidine | 1982 |
[Metabolic modulation as a method in tumor chemotherapy].
Topics: Antineoplastic Agents; Cytarabine; Fluorouracil; Humans; Methotrexate; Neoplasms; Tegafur; Thymidine; Uracil | 1982 |
An overview of thymidine.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Clinical Trials as Topic; Cytarabine; DNA, Neoplasm; Drug Therapy, Combination; Fluorouracil; Humans; Methotrexate; Methylthioinosine; Mice; Neoplasms; Thymidine | 1980 |
Determinants of response to antimetabolites and their modulation by normal purine and pyrimidine metabolites.
Topics: Animals; Antimetabolites, Antineoplastic; Cytarabine; DNA, Neoplasm; Fluorodeoxyuridylate; Fluorouracil; Humans; Leukemia L1210; Neoplasms; Neoplasms, Experimental; Thymidine; Thymidylate Synthase; Uridine | 1981 |
[Design of antitumor 2'-deoxy-(2'-C-substituted) cytidines].
Topics: Animals; Antineoplastic Agents; Cytarabine; Drug Design; Drug Stability; Humans; Neoplasms; Tumor Cells, Cultured | 1995 |
New targets for pyrimidine antimetabolites for the treatment of solid tumours. 2: Deoxycytidine kinase.
Topics: Animals; Antimetabolites, Antineoplastic; Biotransformation; Cytarabine; Deoxycytidine Kinase; Drug Resistance; Humans; Neoplasms | 1994 |
Epipodophyllotoxins in the treatment of childhood cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cytarabine; Etoposide; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Neoplasms; Neoplasms, Second Primary; Neuroblastoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide | 1994 |
Clinical pharmacokinetics of anti-metabolites.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Cytarabine; Fluorouracil; Humans; Mercaptopurine; Methotrexate; Neoplasms | 1993 |
Peripheral blood progenitor cell transplantation: a single centre experience comparing two mobilisation regimens in 67 patients.
Topics: Adolescent; Adult; Amyloidosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carmustine; Cell Movement; Colony-Forming Units Assay; Cyclophosphamide; Cytarabine; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Kidney Diseases; Leukapheresis; Leukocyte Count; Male; Melphalan; Middle Aged; Neoplasms; Podophyllotoxin; Retrospective Studies; Thiotepa; Transplantation Conditioning | 1996 |
[Why is the DNA-strand-breaker, PCNDAC, effective to solid tumors?].
Topics: Animals; Apoptosis; Cytarabine; DNA Damage; DNA, Neoplasm; Drug Design; Gene Deletion; Genes, p53; Humans; Mice; Mice, Nude; Necrosis; Neoplasms; Point Mutation; Prodrugs; RNA, Neoplasm | 1998 |
Modulation of drug-induced apoptosis by interruption of the protein kinase C signal transduction pathway: a new therapeutic strategy.
Topics: Antineoplastic Agents; Apoptosis; Bryostatins; Cytarabine; Drug Synergism; Enzyme Inhibitors; Humans; Lactones; Macrolides; Neoplasms; Protein Kinase C; Protein-Tyrosine Kinases; Signal Transduction | 1996 |
Therapeutic drug monitoring of antimetabolic cytotoxic drugs.
Topics: Antimetabolites, Antineoplastic; Cytarabine; Drug Monitoring; Fluorouracil; Humans; Mercaptopurine; Methotrexate; Neoplasms | 1999 |
Chemotherapy-induced neurotoxicity: assessment and interventions for patients at risk.
Topics: Antineoplastic Agents; Cisplatin; Cytarabine; Humans; Ifosfamide; Methotrexate; Neoplasms; Neurotoxicity Syndromes; Nursing Assessment; Oncology Nursing; Paclitaxel; Vinca Alkaloids | 2002 |
Advances in cancer chemotherapy.
Topics: Bleomycin; Burkitt Lymphoma; Carcinoma, Basal Cell; Choriocarcinoma; Cyclophosphamide; Cytarabine; Dacarbazine; Doxorubicin; Female; Humans; Lomustine; Lung Neoplasms; Methotrexate; Mitosis; Neoplasms; Pregnancy; Skin Neoplasms; Vincristine | 1975 |
Immunologic aspects of cancer chemotherapy.
Topics: Animals; BCG Vaccine; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Fluorouracil; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Immunotherapy; Levamisole; Mercaptopurine; Methotrexate; Mice; Neoplasms; Propionibacterium acnes; Vinca Alkaloids | 1977 |
Multiple basis of combination chemotherapy.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Antagonism; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Humans; Leucovorin; Mercaptopurine; Methotrexate; Neoplasms; Neoplasms, Experimental; Uridine | 1977 |
ARA-C analogs.
Topics: Clinical Trials as Topic; Cytarabine; Deamination; Drug Administration Schedule; Female; Half-Life; Humans; Neoplasms | 1978 |
Chemotherapy of non-Hodgkin lymphoma: the diffuse types.
Topics: Antineoplastic Agents; Central Nervous System Diseases; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Humans; Leucovorin; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasms; Prednisone; Remission, Spontaneous; Vincristine | 1978 |
[Molecular mechanisms of the occurrence of tumor drug resistance and ways to overcome it].
Topics: Alkylating Agents; Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cytarabine; Drug Resistance; Drug Synergism; Humans; Molecular Biology; Neoplasms; Neoplasms, Experimental; Phenotype; Purines; Pyrimidine Nucleosides; Pyrimidines | 1978 |
Drug latentiation in cancer chemotherapy.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Cytarabine; Drug Evaluation; Drug Evaluation, Preclinical; Enzymes; Humans; Liver; Neoplasms; Nitrogen Mustard Compounds | 1978 |
Selective suppression of humoral immunity by antineoplastic drugs.
Topics: Animals; Antineoplastic Agents; Binding Sites; Chickens; Cyclophosphamide; Cytarabine; Fluorouracil; Guinea Pigs; Humans; Immunity; Immunity, Cellular; Immunosuppressive Agents; Leucovorin; Male; Mercaptopurine; Methotrexate; Mice; Neoplasms; Piperazines; Rats; Stimulation, Chemical | 1976 |
Recent developments in chemotherapy of malignancy.
Topics: Alkaloids; Alkylating Agents; Antibiotics, Antineoplastic; Antimetabolites; Antineoplastic Agents; Cell Survival; Child; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Humans; Immunotherapy; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasms; Plants, Medicinal; Vincristine | 1975 |
Hypersensitivity reactions.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Asparaginase; Aziridines; Benzoquinones; Bleomycin; Chlorambucil; Cisplatin; Cyclophosphamide; Cytarabine; Dacarbazine; Drug Hypersensitivity; Etoposide; Fluorouracil; Humans; Ifosfamide; Melphalan; Methotrexate; Mitomycins; Neoplasms; Paclitaxel; Pentostatin; Procarbazine; Teniposide | 1992 |
Antimetabolites.
Topics: Animals; Cytarabine; Drug Interactions; Drug Resistance; Fluorouracil; Humans; Methotrexate; Neoplasms | 1992 |
Idarubicin: an anthracycline antineoplastic agent.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Breast Neoplasms; Cytarabine; Drug Labeling; Humans; Idarubicin; Leukemia, Myeloid, Acute; Lung Neoplasms; Lymphoma; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1992 |
Antimetabolites.
Topics: Animals; Antimetabolites; Antineoplastic Agents; Cytarabine; Cytidine; Drug Interactions; Drug Resistance; Floxuridine; Fluorouracil; Folic Acid Antagonists; Humans; Methotrexate; Neoplasms | 1991 |
Idarubicin: a second-generation anthracycline.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cytarabine; Drug Evaluation; Humans; Idarubicin; Leukemia; Neoplasms; Remission Induction | 1991 |
Clinical use of differentiating agents in cancer therapy.
Topics: Acetamides; Animals; Antineoplastic Agents; Cell Differentiation; Cytarabine; Humans; Neoplasms; Retinoids | 1990 |
Intracavitary chemotherapy.
Topics: Absorption; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Ascitic Fluid; Bacterial Infections; Bleomycin; Cisplatin; Cytarabine; Diffusion; Doxorubicin; Drug Synergism; Female; Fluorouracil; Humans; Immunotherapy; Melphalan; Methotrexate; Mitomycins; Neoplasms; Ovarian Neoplasms; Peritoneal Cavity; Permeability; Pleura; Pleural Effusion; Radiation-Sensitizing Agents; Sclerosis; Streptozocin | 1985 |
[Prolonged intravenous infusion chemotherapy. General review of theoretical bases and results].
Topics: Antineoplastic Agents; Bleomycin; Cell Cycle; Cisplatin; Clinical Trials as Topic; Cytarabine; Doxorubicin; Fluorouracil; Humans; Infusions, Parenteral; Neoplasms; Podophyllotoxin; Time Factors; Vinca Alkaloids | 1985 |
[Use of recombinant hematopoietic growth factors after chemotherapy and high-dose chemo-radiotherapy].
Topics: Anemia, Aplastic; Antineoplastic Agents; Colony-Stimulating Factors; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Evaluation; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Melphalan; Neoplasms; Radiotherapy | 1989 |
Cancer chemotherapy in infants and children.
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Bleomycin; Catheters, Indwelling; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Cytarabine; Dacarbazine; Dactinomycin; Daunorubicin; Doxorubicin; Humans; Infant; Infant, Newborn; Infusions, Parenteral; Mercaptopurine; Methotrexate; Neoplasms; Nitrosourea Compounds; Thioguanine; Vinblastine; Vincristine | 1985 |
Role of thymidine in biochemical modulation: a review.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Cytarabine; Deoxycytidine Kinase; DNA Replication; DNA, Neoplasm; Drug Evaluation; Drug Synergism; Fluorouracil; Folic Acid Antagonists; Humans; Interphase; Kinetics; Leukemia; Methotrexate; Mice; Neoplasms; Neoplasms, Experimental; Nucleic Acid Synthesis Inhibitors; Nucleotides; Phosphonoacetic Acid; RNA, Neoplasm; Species Specificity; Thymidine | 1987 |
Cell cycle analysis using flow cytometry.
Topics: Animals; Antibodies, Monoclonal; Bromodeoxyuridine; Cell Cycle; Cell Line; Cytarabine; DNA; DNA, Neoplasm; Flow Cytometry; Fluorescent Antibody Technique; Humans; Interphase; Kinetics; Mathematics; Mitosis; Models, Biological; Neoplasms; Sarcoma, Experimental | 1986 |
Overview of the clinical relevance of autologous bone marrow transplantation.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Evaluation; Drug Resistance; Etoposide; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Melphalan; Neoplasm Recurrence, Local; Neoplasms; Thioguanine; Transplantation, Autologous | 1986 |
Indications for and benefits of intensive therapies in treatment of childhood cancers.
Topics: Acute Disease; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Etoposide; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Melphalan; Methotrexate; Neoplasms; Osteosarcoma; Risk; Sarcoma, Ewing | 1986 |
Differentiating agents in the treatment of human malignancies.
Topics: Antineoplastic Agents; Cell Line; Clinical Trials as Topic; Cytarabine; Drug Evaluation; Humans; Neoplasms; Research Design; Tumor Stem Cell Assay | 1986 |
The intracavitary administration of cytarabine to patients with nonhematopoietic malignancies: pharmacologic rationale and results of clinical trials.
Topics: Abdomen; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Cisplatin; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Drug Evaluation; Female; Humans; Kidney Diseases; Kinetics; Leukopenia; Nausea; Neoplasms; Ovarian Neoplasms; Pain; Peritoneal Cavity; Peritonitis; Pleura; Thrombocytopenia; Vomiting | 1985 |
Antitumor effects of immobilized protein A and staphylococcal products: linkage between toxicity and efficacy, and identification of potential tumoricidal reagents.
Topics: Animals; Collodion; Complement System Proteins; Cytarabine; Dogs; Drug Synergism; Enterotoxins; Humans; Immunoglobulins; Lymphocyte Activation; Lymphocytes; Mitogens; Neoplasms; Staphylococcal Protein A | 1985 |
Guide to the use of cancer chemotherapeutic agents.
Topics: Alkylating Agents; Allopurinol; Antibiotics, Antineoplastic; Antimetabolites; Antineoplastic Agents; Asparaginase; Azaserine; Azauridine; Bleomycin; Camptothecin; Carmustine; Cell Division; Cyclophosphamide; Cytarabine; Dactinomycin; Daunorubicin; Doxorubicin; Fluorouracil; Humans; Kinetics; Neoplasms; Nitrogen Mustard Compounds; Procarbazine; Triazines; Vincristine | 1972 |
Cancer chemotherapy. II.
Topics: Animals; Antineoplastic Agents; Asparaginase; Azathioprine; Bleomycin; Cytarabine; Dactinomycin; Daunorubicin; Dimethylamines; Doxorubicin; Floxuridine; Fluorouracil; Humans; Hydroxyurea; Imidazoles; Mercaptopurine; Mitomycins; Mitotane; Neoplasms; Nitrosourea Compounds; Pipobroman; Procarbazine; Streptonigrin; Streptozocin; Thioguanine; Triazenes; Triazines; Vinblastine; Vincristine | 1972 |
Combination cancer therapy: Presidential address.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Bleomycin; Cell Division; Cytarabine; DNA Replication; Hodgkin Disease; Humans; Immunosuppression Therapy; Leukemia, Lymphoid; Mice; Neoplasm Metastasis; Neoplasms; Neoplasms, Experimental; Prognosis; Remission, Spontaneous; Time Factors; Vincristine | 1972 |
Biochemical aspects of drug combinations.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Bleomycin; Camptothecin; Cell Division; Cytarabine; Deferoxamine; Diamines; DNA, Neoplasm; Doxorubicin; Drug Therapy, Combination; Leukemia L1210; Macromolecular Substances; Mice; Neoplasms; Neoplasms, Experimental; Nitrosourea Compounds; Purine Nucleotides; Ribonucleotide Reductases; Thioguanine; Triazoles | 1974 |
[Principles of the effect of cytostatics].
Topics: Antineoplastic Agents; Asparaginase; Cell Division; Chlorambucil; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Fluorouracil; Folic Acid Antagonists; Humans; Melphalan; Mercaptopurine; Methotrexate; Neoplasms; Triaziquone; Triethylenephosphoramide; Vincristine | 1974 |
An assessment of massive-dose chemotherapy of malignant disease.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bone Marrow; Bone Marrow Cells; Cell Division; Cyclophosphamide; Cytarabine; Female; Fluorouracil; Humans; Leukemia L1210; Leukemia, Lymphoid; Lymphoma; Melphalan; Mercaptopurine; Methotrexate; Mice; Multiple Myeloma; Neoplasms; Nitrogen Mustard Compounds; Prednisone; Pregnancy; Time Factors; Trophoblastic Neoplasms; Vinblastine | 1971 |
The emergence of drug resistance in tumours: a characteristic which may be exploited therapeutically.
Topics: Aminohydrolases; Animals; Cytarabine; Cytidine; DNA; Drug Resistance; Humans; Leukemia; Leukemia L1210; Methotrexate; Neoplasms | 1973 |
Rationale of combination chemotherapy based on preclinical experiments.
Topics: Animals; Antineoplastic Agents; Azaguanine; Carcinoma; Cytarabine; Drug Synergism; Humans; Hydroxyurea; Immunotherapy; Leukemia L1210; Lung Neoplasms; Melanoma; Neoplasms; Thiosemicarbazones; Time Factors | 1973 |
Toward a chronotherapy of neoplasia: tolerance of treatment depends upon host rhythms.
Topics: Animals; Antineoplastic Agents; Bone Marrow Cells; Circadian Rhythm; Cytarabine; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Tolerance; Duodenum; Female; Humans; Infant, Newborn; Leukemia, Experimental; Leukocytes; Liver; Mice; Mitosis; Models, Biological; Neoplasms; Pancreas; Radiation Injuries, Experimental; Rats; Skin | 1973 |
Predictive tests in cancer. Tuesday 9 April 1974.
Topics: Age Factors; Breast Neoplasms; Cell Movement; Clinical Enzyme Tests; Colonic Neoplasms; Cytarabine; Diagnosis, Differential; Doxorubicin; Drug Combinations; Drug Evaluation; Drug Evaluation, Preclinical; Fluorouracil; Humans; Kinetics; Leukemia; Mercaptopurine; Methods; Methotrexate; Models, Chemical; Neoplasms; Prognosis; Sarcoma; Testosterone; Thioguanine | 1974 |
[A review of clinical tumor immunology. An approach to immunochemotherapy].
Topics: Animals; Antibiotics, Antineoplastic; BCG Vaccine; Cytarabine; Drug Therapy, Combination; Fluorouracil; Freund's Adjuvant; Humans; Hypersensitivity, Delayed; Immunity; Immunity, Cellular; Immunoglobulins; Immunotherapy; Leukocytes; Lymphocytes; Mice; Neoplasm Regression, Spontaneous; Neoplasms; Pancreatic Neoplasms; Stomach Neoplasms; Streptococcus; Toxins, Biological | 1974 |
Immunochemotherapy of human cancer.
Topics: Acute Disease; Adjuvants, Immunologic; Adult; Animals; Antineoplastic Agents; BCG Vaccine; Cytarabine; Humans; Immunosuppressive Agents; Immunotherapy; Leukemia L1210; Lymphoma; Melanoma; Mice; Neoplasms; Neoplasms, Experimental; Prednisone; Vincristine | 1974 |
[Progress in the drug therapy of cancer].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Asparaginase; Cytarabine; Daunorubicin; Drug Synergism; Humans; Hydrazines; Hydroxyurea; Neoplasms; Nitroso Compounds; Picolinic Acids; Pyrogallol; Quinolines; Streptonigrin; Urea | 1968 |
Cancer chemotherapy.
Topics: Alkaloids; Amides; Animals; Antineoplastic Agents; Asparaginase; Cell Division; Colchicine; Cytarabine; DNA; Griseofulvin; Humans; Hydroxyurea; Mice; Neoplasms; Nucleosides; Thiosemicarbazones; Vinblastine; Vincristine | 1969 |
Factors pertaining to complete drug-induced remission of tumor in animals and man.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Cytarabine; Humans; Leukemia L1210; Methotrexate; Mice; Neoplasms; Nitroso Compounds; Urea | 1969 |
[Antimetabolites].
Topics: Allopurinol; Animals; Antimetabolites; Azathioprine; Cell Division; Chemical Phenomena; Chemistry; Cytarabine; DNA, Neoplasm; Fluorouracil; Folic Acid Antagonists; Humans; Leukemia; Mercaptopurine; Methotrexate; Neoplasms; Pyrimidines; Thioguanine | 1971 |
The chemotherapy of human and animal acute leukemia.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Asparaginase; Azaserine; Cell Division; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Disease Models, Animal; Drug Combinations; Humans; Kinetics; Leukemia L1210; Leukemia, Experimental; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Mercaptopurine; Methotrexate; Neoplasms; Prednisone; Remission, Spontaneous; RNA, Neoplasm; Vincristine | 1971 |
Multiple combination therapy in cancer chemotherapy in Japan.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Chloroquine; Cyclophosphamide; Cytarabine; Drug Synergism; Fluorouracil; Humans; Japan; Leukemia; Lymphoma; Mercaptopurine; Mitomycins; Neoplasms; Podophyllin; Prednisolone; Thiotepa; Vincristine; Vitamin K 1 | 1969 |
39 trial(s) available for cytarabine and Neoplasms
| Article | Year |
|---|---|
A phase II study of concurrent involved-field radiotherapy and intrathecal chemotherapy for leptomeningeal metastasis from solid tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Humans; Methotrexate; Neoplasms | 2023 |
Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Incidence; Male; Neoplasms; Prednisone; Vincristine | 2021 |
Phase I dose-escalation trial of checkpoint kinase 1 inhibitor MK-8776 as monotherapy and in combination with gemcitabine in patients with advanced solid tumors.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Checkpoint Kinase 1; Cohort Studies; Cytarabine; Deoxycytidine; Female; Gemcitabine; Histones; Humans; Infusions, Intravenous; K562 Cells; Male; Melanoma; Middle Aged; Neoplasms; Protein Kinase Inhibitors; Protein Kinases; Pyrazoles; Pyrimidines; Sarcoma; Time Factors | 2015 |
Phase 2 study of low-dose clofarabine plus cytarabine for patients with higher-risk myelodysplastic syndrome who have relapsed or are refractory to hypomethylating agents.
Topics: Adenine Nucleotides; Adult; Aged; Aged, 80 and over; Arabinonucleosides; Clofarabine; Cytarabine; Disease-Free Survival; DNA Methylation; Female; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasm Proteins; Neoplasms; Treatment Outcome | 2017 |
Phase I Trial of the Human Double Minute 2 Inhibitor MK-8242 in Patients With Advanced Solid Tumors.
Topics: Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Neoplasms; Proto-Oncogene Proteins c-mdm2; Tumor Suppressor Protein p53 | 2017 |
Intravenous administration of CP-4055 (ELACYT) in patients with solid tumours. A Phase I study.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Melanoma; Middle Aged; Neoplasms; Ovarian Neoplasms | 2009 |
Combination therapy with mitomycin C (NSC-26980), 5-fluorouracil (NSC-19893), and cytosine arabinoside (NSC-63878) for advanced cancer in man.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Colorectal Neoplasms; Cytarabine; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasms; Stomach Neoplasms; Treatment Outcome | 1972 |
Route of intracerebrospinal fluid chemotherapy administration and efficacy of therapy in neoplastic meningitis.
Topics: Adult; Cytarabine; Delayed-Action Preparations; Disease-Free Survival; Humans; Injections, Intraventricular; Meningeal Carcinomatosis; Meningitis; Methotrexate; Neoplasms; Spinal Puncture | 2010 |
Quality-of-life-adjusted survival comparison of sustained-release cytosine arabinoside versus intrathecal methotrexate for treatment of solid tumor neoplastic meningitis.
Topics: Adult; Cytarabine; Delayed-Action Preparations; Disease Progression; Humans; Injections, Spinal; Meningeal Neoplasms; Meningitis; Methotrexate; Neoplasms; Quality of Life; Survival Analysis | 2003 |
Glomerular dysfunction, independent of tubular dysfunction, induced by antineoplastic chemotherapy in children.
Topics: Acute Disease; Adolescent; Albuminuria; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Creatinine; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Glomerular Filtration Rate; Humans; Kidney Tubules; Leukemia; Lymphoma; Methotrexate; Neoplasms; Neuroblastoma; Osteosarcoma; Proteinuria; Rhabdomyosarcoma; Vincristine | 2004 |
Clofarabine in adult acute leukemias: clinical success and pharmacokinetics.
Topics: Adenine Nucleotides; Adult; Antimetabolites, Antineoplastic; Arabinonucleosides; Clinical Trials as Topic; Clofarabine; Cohort Studies; Cytarabine; Dose-Response Relationship, Drug; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Models, Chemical; Myelodysplastic Syndromes; Neoplasm Metastasis; Neoplasms; Nucleosides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome | 2004 |
Newer techniques in cancer chemotherapy.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Bleomycin; Bone Marrow Transplantation; Carcinoma; Cells, Cultured; Child; Cisplatin; Clinical Trials as Topic; Colonic Neoplasms; Combined Modality Therapy; Cytarabine; Doxorubicin; Drug Therapy, Combination; Fluorouracil; Hepatic Artery; Humans; Hyperthermia, Induced; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Mechlorethamine; Melanoma; Meningeal Neoplasms; Methotrexate; Neoplasms; Osteosarcoma; Peritoneal Cavity; Pleura | 1984 |
Effective chemotherapy of acute myelocytic leukemia occurring after alkylating agent or radiation therapy for prior malignancy.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cytarabine; Daunorubicin; Drug Administration Schedule; Female; Humans; Leukemia, Myeloid, Acute; Leukemia, Radiation-Induced; Male; Middle Aged; Neoplasms; Prospective Studies; Risk | 1983 |
Cancer chemotherapy. Progress and expectations, 1984.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Cytarabine; Drug Resistance; Fluorouracil; Humans; Neoplasms; Thymidine; Time Factors | 1984 |
An overview of thymidine.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Clinical Trials as Topic; Cytarabine; DNA, Neoplasm; Drug Therapy, Combination; Fluorouracil; Humans; Methotrexate; Methylthioinosine; Mice; Neoplasms; Thymidine | 1980 |
Idarubicin, high-dose cytarabine and etoposide for remission induction in therapy-related acute myeloid leukemia.
Topics: Acute Disease; Adult; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Bone Marrow Diseases; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Etoposide; Female; Gastrointestinal Diseases; Humans; Idarubicin; Leukemia, Myeloid; Leukemia, Radiation-Induced; Male; Middle Aged; Neoplasms; Prospective Studies; Radiotherapy; Remission Induction; Salvage Therapy; Treatment Outcome | 1994 |
Peripheral blood progenitor cell transplantation: a single centre experience comparing two mobilisation regimens in 67 patients.
Topics: Adolescent; Adult; Amyloidosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carmustine; Cell Movement; Colony-Forming Units Assay; Cyclophosphamide; Cytarabine; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Kidney Diseases; Leukapheresis; Leukocyte Count; Male; Melphalan; Middle Aged; Neoplasms; Podophyllotoxin; Retrospective Studies; Thiotepa; Transplantation Conditioning | 1996 |
Correlation between granulocyte/macrophage-colony-forming units and CD34+ cells in apheresis products from patients treated with different chemotherapy regimens and granulocyte-colony-stimulating factor to mobilize peripheral blood progenitor cells.
Topics: Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Component Removal; Carmustine; Cell Separation; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Epirubicin; Etoposide; Female; Flow Cytometry; Granulocyte Colony-Stimulating Factor; Granulocytes; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Humans; Ifosfamide; Macrophages; Male; Melphalan; Neoplasms; Prednisolone; Vincristine | 1998 |
A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Brain Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cytarabine; Delayed-Action Preparations; Disease Progression; Female; Humans; Injections, Spinal; Lung Neoplasms; Male; Melanoma; Meningeal Neoplasms; Methotrexate; Middle Aged; Neoplasms; Prospective Studies; Survival Rate; Survivors | 1999 |
Phase II study of anhydro-ara-5-fluorocytidine in adenocarcinoma of gastrointestinal tract, epidermoid carcinoma of lung, head and neck, breast carcinoma and small cell anaplastic carcinoma of lung. A study report of the E.O.R.T.C. early clinical trial co
Topics: Ancitabine; Breast Neoplasms; Cytarabine; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Hematologic Diseases; Humans; Lung Neoplasms; Neoplasms | 1978 |
Ineffectiveness of subcutaneous cytosine arabinoside in localized herpes zoster.
Topics: Adult; Aged; Antibodies, Viral; Blood Platelets; Clinical Trials as Topic; Complement Fixation Tests; Cytarabine; Female; Herpes Zoster; Herpesvirus 3, Human; Humans; Injections, Subcutaneous; Leukocyte Count; Male; Middle Aged; Neoplasms; Neutrophils; Pain; Placebos; Research Design; Urticaria | 1975 |
ARA-C analogs.
Topics: Clinical Trials as Topic; Cytarabine; Deamination; Drug Administration Schedule; Female; Half-Life; Humans; Neoplasms | 1978 |
Design of adjuvant chemotherapy based on target cell determinants of drug action: possibilities and limitations.
Topics: Animals; Antineoplastic Agents; Clinical Trials as Topic; Cytarabine; Drug Evaluation; Humans; Leukemia, Experimental; Leukemia, Myeloid, Acute; Mice; Neoplasms; Research Design | 1979 |
Phase I evaluation of tetrahydrouridine combined with cytosine arabinoside.
Topics: Bone Marrow; Clinical Trials as Topic; Cytarabine; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Humans; Leukemia; Lymphoma; Middle Aged; Neoplasms; Nucleoside Deaminases; Pyrimidine Nucleosides; Tetrahydrouridine; Uridine | 1979 |
Toxicity of high-dose cytosine arabinoside in the treatment of advanced childhood tumors resistant to conventional therapy. A Pediatric Oncology Group study.
Topics: Child; Cytarabine; Drug Administration Schedule; Fibrosarcoma; Humans; Infusions, Intravenous; Nausea; Neoplasms; Neuroblastoma; Pilot Projects; Rhabdomyosarcoma; Vomiting | 1990 |
[Prolonged intravenous infusion chemotherapy. General review of theoretical bases and results].
Topics: Antineoplastic Agents; Bleomycin; Cell Cycle; Cisplatin; Clinical Trials as Topic; Cytarabine; Doxorubicin; Fluorouracil; Humans; Infusions, Parenteral; Neoplasms; Podophyllotoxin; Time Factors; Vinca Alkaloids | 1985 |
Intracavitary chemotherapy.
Topics: Anthraquinones; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Catheters, Indwelling; Cisplatin; Clinical Trials as Topic; Cytarabine; Doxorubicin; Etoposide; Fluorouracil; Humans; Immunotherapy; Infusions, Parenteral; Melphalan; Methotrexate; Mitomycins; Mitoxantrone; Neoplasms; Organoplatinum Compounds | 1986 |
Principal results of the Medical Research Council's 8th acute myeloid leukaemia trial.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Central Nervous System Diseases; Child; Child, Preschool; Clinical Trials as Topic; Cytarabine; Daunorubicin; Drug Administration Schedule; Humans; Infant; Leukemia, Myeloid, Acute; Middle Aged; Neoplasm Recurrence, Local; Neoplasms; Prognosis; Random Allocation; Thioguanine | 1986 |
Overview of the clinical relevance of autologous bone marrow transplantation.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Evaluation; Drug Resistance; Etoposide; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Melphalan; Neoplasm Recurrence, Local; Neoplasms; Thioguanine; Transplantation, Autologous | 1986 |
2'-Fluoro-5-iodoarabinosylcytosine, a new potent antiviral agent: efficacy in immunosuppressed individuals with herpes zoster.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Chemical Phenomena; Chemistry; Child; Clinical Trials as Topic; Cytarabine; Double-Blind Method; Female; Herpes Zoster; Humans; Immune Tolerance; Male; Middle Aged; Nausea; Neoplasms; Random Allocation; Vidarabine; Vomiting | 1986 |
[Comparative clinical study of MF(mitomycin and 5-fluorouracil) and MF.BH-AC therapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Colonic Neoplasms; Cytarabine; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycins; Neoplasms; Stomach Neoplasms | 1986 |
Differentiating agents in the treatment of human malignancies.
Topics: Antineoplastic Agents; Cell Line; Clinical Trials as Topic; Cytarabine; Drug Evaluation; Humans; Neoplasms; Research Design; Tumor Stem Cell Assay | 1986 |
[Short term toxicity and efficacy of 4 different cytosine-arabinoside regimens in 40 cases of human solid tumors].
Topics: Blood Cell Count; Blood Platelets; Clinical Trials as Topic; Cytarabine; Erythrocytes; Humans; Leukocytes; Neoplasm Metastasis; Neoplasms | 1972 |
Failure of cytarabine in varicella-zoster infections.
Topics: Acute Disease; Adolescent; Adult; Aged; Chickenpox; Clinical Trials as Topic; Cytarabine; DNA, Viral; Female; Herpes Zoster; Herpesvirus 3, Human; Humans; Immunosuppressive Agents; Male; Middle Aged; Neoplasms; Placebos; Time Factors; Virus Replication | 1973 |
Cytosine arabinoside for localized herpes zoster in patients with cancer: failure in a controlled trial.
Topics: Clinical Trials as Topic; Cytarabine; Herpes Zoster; Herpesvirus 3, Human; Hodgkin Disease; Humans; Infusions, Parenteral; Lymphoma; Neoplasms; Placebos | 1974 |
A clinical evaluation of dose and schedule of administration of cytosine arabinoside (NSC 63878).
Topics: Blood Chemical Analysis; Bone Marrow; Bone Marrow Cells; Clinical Trials as Topic; Cytarabine; Humans; Infusions, Parenteral; Injections, Intravenous; Leukocyte Count; Neoplasms | 1968 |
Clinical trials of 1-beta-D-arabinofuranosyl cytosine and 1,3-bis-(2-chloroethyl)-1-nitrosourea combination in metastatic cancer and acute leukemia.
Topics: Age Factors; Blood Cell Count; Blood Platelets; Blood Urea Nitrogen; Clinical Trials as Topic; Cytarabine; Drug Synergism; Female; Hemoglobins; Humans; Injections, Intravenous; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Nitrogen Mustard Compounds; Nitroso Compounds; Nitrosourea Compounds; Remission, Spontaneous; Reticulocytes; Sex Factors; Urea; Uric Acid | 1971 |
The chemotherapy of human and animal acute leukemia.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Asparaginase; Azaserine; Cell Division; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Disease Models, Animal; Drug Combinations; Humans; Kinetics; Leukemia L1210; Leukemia, Experimental; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Mercaptopurine; Methotrexate; Neoplasms; Prednisone; Remission, Spontaneous; RNA, Neoplasm; Vincristine | 1971 |
Cytosine arabinoside (NSC-63878)--clinical brochure.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Clinical Trials as Topic; Cytarabine; Dogs; Haplorhini; Humans; Leukemia L1210; Mice; Neoplasms; Rats | 1968 |
201 other study(ies) available for cytarabine and Neoplasms
| Article | Year |
|---|---|
Elevated activities of alpha-2-and alpha-3-fucosyltransferases in human serum as a new indicator of malignancy.
Topics: Clinical Enzyme Tests; Guanosine Diphosphate Fucose; Hepatitis, Viral, Human; Hexosyltransferases; Humans; Neoplasms | 1976 |
The presence of CA19-9 in serum and saliva from Lewis blood-group negative cancer patients.
Topics: Antigens, Neoplasm; Antigens, Tumor-Associated, Carbohydrate; Blood Grouping and Crossmatching; Enzyme Precursors; Female; Fucosyltransferases; Guanosine Diphosphate Fucose; Humans; Lewis Blood Group Antigens; Male; Neoplasms; Phenotype; Saliva | 1988 |
Nucleosides and nucleotides. 94. Radical deoxygenation of tert-alcohols in 1-(2-C-alkylpentofuranosyl) pyrimidines: synthesis of (2'S)-2'-deoxy-2'-C-methylcytidine, an antileukemic nucleoside.
Topics: Animals; Antimetabolites, Antineoplastic; Deoxycytidine; Drug Screening Assays, Antitumor; Humans; Indicators and Reagents; Leukemia; Leukemia L1210; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Molecular Structure; Neoplasms; Structure-Activity Relationship | 1991 |
Synthesis, DNA intercalation and 3D QSAR analysis of cis-2,4,5-trisubstituted-1,3-dithiolanes as a novel class of antitumor agents.
Topics: Animals; Antineoplastic Agents; DNA; Heterocyclic Compounds; Intercalating Agents; Mice; Molecular Conformation; Neoplasms; Quantitative Structure-Activity Relationship | 2009 |
Novel effects of glycyrrhetinic acid on the central nervous system tumorigenic progenitor cells: induction of actin disruption and tumor cell-selective toxicity.
Topics: Actins; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Central Nervous System; Genes, myc; Genes, ras; Glycyrrhetinic Acid; Humans; Mice; Neoplasms; Stem Cells; Transfection | 2010 |
A class of novel carboline intercalators: Their synthesis, in vitro anti-proliferation, in vivo anti-tumor action, and 3D QSAR analysis.
Topics: Amino Acids; Animals; Antineoplastic Agents; Carbolines; Cattle; Cell Line, Tumor; Cell Proliferation; DNA; HeLa Cells; Humans; Inhibitory Concentration 50; Intercalating Agents; Mice; Models, Molecular; Neoplasms; Quantitative Structure-Activity Relationship | 2010 |
Synthesis of 3'-azido-3'-deoxythymidine (AZT)--Cinchona alkaloid conjugates via click chemistry: Toward novel fluorescent markers and cytostatic agents.
Topics: Antineoplastic Agents; Azides; Cell Line, Tumor; Cinchona; Cinchona Alkaloids; Fluorescent Dyes; Humans; Neoplasms; Thymidine | 2011 |
Structure-activity relationship and molecular mechanisms of ethyl 2-amino-6-(3,5-dimethoxyphenyl)-4-(2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (CXL017) and its analogues.
Topics: Antineoplastic Agents; Benzopyrans; Cell Line, Tumor; Cell Survival; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; HCT116 Cells; HL-60 Cells; HT29 Cells; Humans; Inhibitory Concentration 50; K562 Cells; Mitoxantrone; Molecular Structure; Neoplasms; Paclitaxel; Stereoisomerism; Structure-Activity Relationship; Vincristine | 2011 |
Structure-Activity Relationships of Neplanocin A Analogues as S-Adenosylhomocysteine Hydrolase Inhibitors and Their Antiviral and Antitumor Activities.
Topics: Adenine; Adenosine; Adenosylhomocysteinase; Animals; Antineoplastic Agents; Antiviral Agents; Cell Line, Tumor; Chlorocebus aethiops; Enzyme Inhibitors; Humans; Molecular Docking Simulation; Neoplasms; Structure-Activity Relationship; Vero Cells; Virus Diseases; Viruses | 2015 |
Synthesis and anticancer activity of some 5-fluoro-2'-deoxyuridine phosphoramidates.
Topics: Amides; Antineoplastic Agents; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxyuridine; Humans; Neoplasms; Phosphoric Acids | 2016 |
Discovery of 4-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-N-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-1H-pyrazole-3-carboxamide (FN-1501), an FLT3- and CDK-Kinase Inhibitor with Potentially High Efficiency against Acute Myelocytic Leukemia.
Topics: Amides; Animals; Antineoplastic Agents; Cell Line, Tumor; Cyclin-Dependent Kinases; Drug Discovery; fms-Like Tyrosine Kinase 3; Heterografts; Humans; Leukemia, Myeloid, Acute; Mice; Neoplasms; Protein Kinase Inhibitors; Pyrazoles; Structure-Activity Relationship | 2018 |
Discovery of a potent MLL1 and WDR5 protein-protein interaction inhibitor with in vivo antitumor activity.
Topics: Animals; Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Screening Assays, Antitumor; Histone-Lysine N-Methyltransferase; Humans; Intracellular Signaling Peptides and Proteins; Kinetics; Mice; Mice, Nude; Molecular Docking Simulation; Myeloid-Lymphoid Leukemia Protein; Neoplasms; Protein Binding; Protein Interaction Maps; Structure-Activity Relationship; Transplantation, Heterologous; Triazoles | 2021 |
Carrier-Free Nanoplatform via Evoking Pyroptosis and Immune Response against Breast Cancer.
Topics: Animals; Cell Line, Tumor; Cytarabine; Immunity; Mice; Nanoparticles; Neoplasms; Photochemotherapy; Photosensitizing Agents; Pyroptosis | 2023 |
Enzymatic rhamnosylation of anticancer drugs by an α-L-rhamnosidase from Alternaria sp. L1 for cancer-targeting and enzyme-activated prodrug therapy.
Topics: Alternaria; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cytarabine; Floxuridine; Glycoside Hydrolases; Humans; Hydroxyurea; Molecular Targeted Therapy; Neoplasms; Prodrugs; Rhamnose | 2019 |
Assessment of Anti-Tumor potential and safety of application of Glutathione stabilized Gold Nanoparticles conjugated with Chemotherapeutics.
Topics: Chromatography, High Pressure Liquid; Cytarabine; Deoxycytidine; Doxorubicin; Gemcitabine; Glutathione; Gold; Humans; MCF-7 Cells; Metal Nanoparticles; Microscopy, Electron, Transmission; Neoplasms; Osteoblasts; Telomerase | 2020 |
Proteome activity landscapes of tumor cell lines determine drug responses.
Topics: Adenylate Kinase; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Computational Biology; Computer Simulation; Cytarabine; Drug Development; Genomics; Humans; Leukemia, Myeloid, Acute; Neoplasms; Proteome; Proteomics; Raloxifene Hydrochloride; Receptors, Progesterone; Signal Transduction | 2020 |
Alpha-lipoic acid ameliorates cytarabine-induced developmental anomalies in rat fetus.
Topics: Abnormalities, Drug-Induced; Animals; Antineoplastic Agents; Cytarabine; Female; Fetal Development; Humans; Models, Animal; Neoplasms; Protective Agents; Rats; Thioctic Acid | 2021 |
AraC-FdUMP[10] Is a Next-Generation Fluoropyrimidine with Potent Antitumor Activity in PDAC and Synergy with
Topics: Animals; Antimetabolites, Antineoplastic; Cytarabine; Female; GTPase-Activating Proteins; Humans; Mice; Mice, Nude; Neoplasms | 2021 |
Depletion of H3K36me2 recapitulates epigenomic and phenotypic changes induced by the H3.3K36M oncohistone mutation.
Topics: Animals; Antimetabolites, Antineoplastic; Carcinogenesis; Cell Line; Chromatin; CRISPR-Cas Systems; Cytarabine; Decitabine; Epigenesis, Genetic; Gene Editing; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Mesenchymal Stem Cells; Methylation; Mice; Mutation; Neoplasm Proteins; Neoplasms; Phenotype; Protein Isoforms; Protein Processing, Post-Translational; Repressor Proteins; Transcriptome | 2021 |
Drug ranking using machine learning systematically predicts the efficacy of anti-cancer drugs.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Computational Biology; Cytarabine; Drug Screening Assays, Antitumor; Hep G2 Cells; Humans; Leukemia; Machine Learning; Neoplasms; Prognosis; Proteomics | 2021 |
BeEAM conditioning regimen is a safe, efficacious and economical alternative to BEAM chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Middle Aged; Neoplasms; Outcome Assessment, Health Care; Podophyllotoxin; Transplantation Conditioning | 2021 |
Improved assessment of mediastinal and pulmonary pathologies in combined staging CT examinations using a fast-speed acquisition dual-source CT protocol.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Feasibility Studies; Female; Humans; Lung Neoplasms; Male; Mediastinum; Middle Aged; Neoplasms; Pelvis; Radiation Dosage; Radiography, Abdominal; Radiography, Thoracic; Retrospective Studies; Thioguanine; Thoracic Neoplasms; Tomography, X-Ray Computed | 2017 |
Analysis of the prolonged infusion of DFP-10917, a deoxycytidine analog, as a therapeutic strategy for the treatment of human tumor xenografts in vivo.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cytarabine; Deoxycytidine; DNA Breaks, Double-Stranded; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; G2 Phase Cell Cycle Checkpoints; Gemcitabine; Humans; Infusions, Intravenous; Isoflurophate; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mice, SCID; Neoplasms; Paclitaxel; Xenograft Model Antitumor Assays | 2018 |
[Intravenous chemotherapy at home: A pediatric monocentric experience].
Topics: Antineoplastic Agents; Child; Cytarabine; Eye Neoplasms; Female; Glioma; Health Services Accessibility; Hematologic Neoplasms; Home Care Services, Hospital-Based; Humans; Injections, Intravenous; Male; Neoplasms; Oncology Nursing; Pediatric Nursing; Pediatricians; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Time Factors; Vinblastine | 2018 |
A preclinical evaluation of cytarabine prodrug nanofibers assembled from cytarabine-lauric acid conjugate toward solid tumors.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Cytarabine; Drug Carriers; Female; Hand-Foot Syndrome; Humans; Lauric Acids; Mice, Inbred BALB C; Nanofibers; Neoplasms; Prodrugs; Stomatitis; Tumor Burden | 2018 |
Impact of diverse chemotherapeutic agents and external factors on activation of brown adipose tissue in a large patient collective.
Topics: Adipose Tissue, Brown; Adult; Age Factors; Aged; Antineoplastic Agents; Body Mass Index; Cytarabine; Female; Humans; Lymphoma; Male; Middle Aged; Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sex Factors | 2019 |
Neurological and cytological response as potential early predictors of time-to-progression and overall survival in patients with leptomeningeal carcinomatosis treated with intrathecal liposomal cytarabine: a retrospective cohort study.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Cytarabine; Cytodiagnosis; Disease Progression; Female; Follow-Up Studies; Humans; Injections, Spinal; Liposomes; Male; Meningeal Carcinomatosis; Middle Aged; Neoplasm Staging; Neoplasms; Nervous System Diseases; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Young Adult | 2013 |
Safety and Efficacy of Liposomal Cytarabine in the Treatment of Neoplastic Meningitis.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Cytarabine; Drug Administration Schedule; Female; Humans; Injections, Spinal; Kaplan-Meier Estimate; Liposomes; Male; Meningitis; Middle Aged; Neoplasms; Palliative Care; Quality of Life; Retrospective Studies; Treatment Outcome | 2015 |
[Cytidine].
Topics: Antineoplastic Agents; Arabinonucleosides; Cytarabine; Cytidine; Deoxycytidine; Gemcitabine; Humans; Neoplasms | 2015 |
Persistence to anti-cancer treatments in the stationary to proliferating transition.
Topics: Antineoplastic Agents; Biomarkers; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytarabine; Drug Resistance, Neoplasm; Fluorescence; G1 Phase; Humans; Neoplasms; Resting Phase, Cell Cycle; Ubiquitin | 2016 |
Methotrexate and Cytarabine-Loaded Nanocarriers for Multidrug Cancer Therapy. Spectroscopic Study.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Combined Chemotherapy Protocols; Calorimetry, Differential Scanning; Cytarabine; Drug Carriers; Methotrexate; Microscopy, Electron, Transmission; Nanoparticles; Neoplasms; Spectroscopy, Fourier Transform Infrared | 2016 |
Psychosexual development and satisfaction in long-term survivors of childhood cancer: Neurotoxic treatment intensity as a risk indicator.
Topics: Adult; Antineoplastic Agents; Brain Neoplasms; Case-Control Studies; Cranial Irradiation; Cytarabine; Female; Humans; Injections, Spinal; Leukemia; Lymphoma; Male; Methotrexate; Neoplasms; Neurotoxicity Syndromes; Orgasm; Personal Satisfaction; Psychosexual Development; Reproductive Health; Risk Factors; Sexual Partners; Surveys and Questionnaires; Survivors; Thiotepa; Young Adult | 2017 |
Synthesis of dual-action parthenolide prodrugs as potent anticancer agents.
Topics: Antineoplastic Agents; Apoptosis; Catalysis; Cell Line, Tumor; Chemistry Techniques, Synthetic; Cytarabine; Humans; Lactones; Melphalan; Neoplasms; Prodrugs; Sesquiterpenes | 2017 |
Self-reported experience of mucositis in cancer patients who underwent conditioning regimen and stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Mucositis; Multiple Myeloma; Neoplasms; Severity of Illness Index; Whole-Body Irradiation; Young Adult | 2009 |
FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Line; Cell Line, Tumor; Cytarabine; Docetaxel; Drug Therapy; Humans; Kidney; Neoplasms; Nuclear Proteins; Paclitaxel; Pancreatic Neoplasms; Phosphoprotein Phosphatases; Proto-Oncogene Proteins c-akt; Tacrolimus Binding Proteins; Taxoids | 2009 |
Gemcitabine and arabinosylcytosin pharmacogenomics: genome-wide association and drug response biomarkers.
Topics: Antimetabolites, Antineoplastic; Biomarkers; Cytarabine; Deoxycytidine; Ethnicity; Gemcitabine; Genetic Variation; Genome-Wide Association Study; Humans; Inhibitory Concentration 50; Linkage Disequilibrium; Neoplasms; Oligonucleotide Array Sequence Analysis; Pharmacogenetics; Polymorphism, Single Nucleotide; RNA, Messenger | 2009 |
Human adenovirus replication in immunocompetent Syrian hamsters can be attenuated with chlorpromazine or cidofovir.
Topics: Adenoviridae Infections; Adenoviruses, Human; Animals; Biological Transport; Cell Death; Cell Line; Cell Line, Tumor; Cell Nucleus; Chlorpromazine; Cidofovir; Cricetinae; Cytarabine; Cytosine; Humans; Immunocompetence; Mesocricetus; Neoplasms; Organ Specificity; Organophosphonates; Transduction, Genetic; Virus Replication | 2010 |
Neutropenic enterocolitis in children and young adults with cancer: prognostic value of clinical and image findings.
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Child, Preschool; Cytarabine; Enterocolitis, Neutropenic; Humans; Intestines; Neoplasms; Prognosis; Retrospective Studies; Risk Factors; Survival Rate; Ultrasonography | 2010 |
Neurotoxicity of intra-CSF liposomal cytarabine (DepoCyt) administered for the treatment of leptomeningeal metastases: a retrospective case series.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Cytarabine; Disease Progression; Female; Follow-Up Studies; Humans; Injections, Spinal; Liposomes; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Middle Aged; Neoplasm Staging; Neoplasms; Neurotoxicity Syndromes; Prognosis; Prospective Studies; Retrospective Studies | 2012 |
Nature and dynamics of nucleosome release from neoplastic and non-neoplastic cells.
Topics: Apoptosis; Blast Crisis; Cytarabine; Etoposide; Hep G2 Cells; Humans; L-Lactate Dehydrogenase; Leukemia; Neoplasms; Neutrophils; Nucleosomes; Tetradecanoylphorbol Acetate; TNF-Related Apoptosis-Inducing Ligand | 2012 |
Cytosine-based nucleoside analogs are selectively lethal to DNA mismatch repair-deficient tumour cells by enhancing levels of intracellular oxidative stress.
Topics: Adaptor Proteins, Signal Transducing; Antimetabolites, Antineoplastic; Cell Line, Tumor; Cytarabine; DNA Mismatch Repair; DNA Repair-Deficiency Disorders; Humans; MutL Protein Homolog 1; MutS Homolog 2 Protein; Neoplasms; Nuclear Proteins; Nucleosides; Oxidative Stress | 2013 |
Predictive value of circulating immature cell counts in peripheral blood for timing of peripheral blood progenitor cell collection after G-CSF plus chemotherapy-induced mobilization.
Topics: Adolescent; Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Cellular Senescence; Combined Modality Therapy; Cytarabine; Dexamethasone; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Humans; Ifosfamide; Leukapheresis; Male; Middle Aged; Neoplasms; Peripheral Blood Stem Cell Transplantation; Predictive Value of Tests; ROC Curve; Transplantation, Autologous | 2002 |
Viridans streptococci bacteraemia in children with fever and neutropenia: a case-control study of predisposing factors.
Topics: Adolescent; Antimetabolites, Antineoplastic; Bacteremia; Case-Control Studies; Child; Child, Preschool; Cytarabine; Female; Fever; Humans; Infant; Male; Multivariate Analysis; Neoplasms; Neutropenia; Retrospective Studies; Risk Factors; Streptococcal Infections; Viridans Streptococci | 2003 |
SYNERGISM OF THE ANTINEOPLASTIC ACTIVITY OF CYTOSINE ARABINOSIDE BY PORFIROMYCIN.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Body Weight; Cytarabine; Cytosine; Leukemia; Leukemia L1210; Leukemia, Experimental; Mice; Mitomycin; Mitomycins; Neoplasms; Neoplasms, Experimental; Nucleosides; Pharmacology; Porfiromycin; Research; Survival | 1964 |
THE REVERSAL OF CYTOSINE ARABINOSIDE ACTIVITY IN VIVO BY DEOXYCYTIDINE.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cytarabine; Cytosine; Deoxycytidine; Leukemia; Leukemia, Experimental; Neoplasms; Neoplasms, Experimental; Nucleosides; Pharmacology; Research; Sarcoma 180 | 1964 |
THE EFFECT OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE HYDROCHLORIDE ON MURINE NEOPLASMS.
Topics: Animals; Anti-Bacterial Agents; Antibodies; Antineoplastic Agents; Blood Cells; Carcinoma, Ehrlich Tumor; Cortisone; Cytarabine; Cytosine; Leukemia L1210; Leukemia, Experimental; Lymphoma; Mercaptopurine; Methotrexate; Mice; Neoplasms; Neoplasms, Experimental; Pharmacology; Research; Sarcoma 180 | 1964 |
TUMOR AND VIRUS ANTIGENS OF SIMIAN VIRUS 40: DIFFERENTIAL INHIBITION OF SYNTHESIS BY CYTOSINE ARABINOSIDE.
Topics: Antigens; Antigens, Viral; Cytarabine; Cytosine; Humans; Idoxuridine; Metabolism; Neoplasms; Nucleosides; Pharmacology; Research; Simian virus 40 | 1965 |
COMPARATIVE STUDIES OF LEUKEMIC CELLS SENSITIVE AND RESISTANT TO CYTOSINE ARABINOSIDE.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Chromatography; Cytarabine; Cytosine; DNA; DNA, Neoplasm; Leukemia; Leukemia, Experimental; Magnesium; Neoplasms; Nucleosides; Pharmacology; Phosphotransferases; Research; RNA; RNA, Neoplasm; Tissue Culture Techniques | 1965 |
Core binding factor acute myeloid leukemia. Cancer and Leukemia Group B (CALGB) Study 8461.
Topics: Adult; Antimetabolites, Antineoplastic; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Core Binding Factor Alpha 2 Subunit; Cytarabine; DNA-Binding Proteins; Humans; Leukemia, Myeloid, Acute; Neoplasms; Proto-Oncogene Proteins; Transcription Factors; Translocation, Genetic | 2004 |
The treatment of neoplastic meningitis.
Topics: Antineoplastic Agents; Cytarabine; Humans; Injections, Intraventricular; Injections, Spinal; Meningitis; Methotrexate; Neoplasms; Prognosis; Thiotepa | 2004 |
Impact of cytidine deaminase activity on intrinsic resistance to cytarabine in carcinoma cells.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Biological Transport; Cytarabine; Cytidine Deaminase; Deoxycytidine Kinase; Drug Resistance, Neoplasm; Humans; Neoplasms | 2004 |
Immunocytochemical detection of deoxycytidine kinase in pediatric malignancies in relation to in vitro cytarabine sensitivity.
Topics: Antimetabolites, Antineoplastic; Brain; Brain Neoplasms; Cell Line, Tumor; Coloring Agents; Cytarabine; Deoxycytidine Kinase; Drug Resistance, Neoplasm; Humans; Immunohistochemistry; Leukemia; Neoplasms; Retinoblastoma; Tetrazolium Salts; Thiazoles | 2004 |
Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinosylcytosine (ara-C) in leukemia and solid tumor cell lines.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Cell Proliferation; Cytarabine; Deoxycytidine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Fatty Acids; Gemcitabine; Humans; Inhibitory Concentration 50; Leukemia; Mice; Neoplasms; Rats; Time Factors | 2004 |
Lipophilic arabinofuranosyl cytosine derivatives in liposomes.
Topics: Animals; Antimetabolites, Antineoplastic; Blood Proteins; Cell Line, Tumor; Cytarabine; Drug Carriers; Erythrocytes; Humans; Liposomes; Mice; Molecular Structure; Neoplasms | 2005 |
Simultaneous separation and determination of Tarabine PFS and Adriblastine using micellar electrokinetic chromatography and high performance liquid chromatography. Application to some biological fluids.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Chromatography, High Pressure Liquid; Chromatography, Micellar Electrokinetic Capillary; Cytarabine; Doxorubicin; Humans; Molecular Structure; Neoplasms; Reproducibility of Results; Sensitivity and Specificity; Urine | 2005 |
Isolation and characterization of a scFv antibody specific for tumor endothelial marker 1 (TEM1), a new reagent for targeted tumor therapy.
Topics: Antibody Specificity; Antigens, CD; Antigens, Neoplasm; Cell Line; Cytarabine; Cytidine; Humans; Immunoglobulin Fragments; Liposomes; Membrane Proteins; Neoplasm Proteins; Neoplasms; Peptide Library; Recombinant Proteins | 2006 |
Prophylaxis of central venous catheter-related thrombosis with minidose warfarin in patients treated with high-dose chemotherapy and peripheral-blood stem-cell transplantation: retrospective analysis of 228 cancer patients.
Topics: Administration, Oral; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Catheterization, Central Venous; Cytarabine; Female; Hemorrhage; Humans; Male; Melphalan; Neoplasms; Peripheral Blood Stem Cell Transplantation; Platelet Count; Podophyllotoxin; Retrospective Studies; Risk Factors; Transplantation, Homologous; Venous Thrombosis; Warfarin | 2006 |
Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cell Line, Tumor; Cisplatin; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Drug Synergism; Floxuridine; Humans; Irinotecan; Liposomes; Mice; Neoplasms; Xenograft Model Antitumor Assays | 2006 |
Drosophila deoxyribonucleoside kinase mutants with enhanced ability to phosphorylate purine analogs.
Topics: Animals; Antimetabolites; Antineoplastic Agents; Cell Line, Tumor; Cladribine; Cytarabine; Directed Molecular Evolution; Drosophila melanogaster; Genes, Transgenic, Suicide; Genetic Therapy; Glioblastoma; Humans; Lethal Dose 50; Mutation; Neoplasms; Osteosarcoma; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Purines; Substrate Specificity; Transduction, Genetic; Vidarabine | 2007 |
Antiproliferative effects of sapacitabine (CYC682), a novel 2'-deoxycytidine-derivative, in human cancer cells.
Topics: 5'-Nucleotidase; Antineoplastic Agents; Apoptosis; Arabinonucleosides; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Cytarabine; Cytosine; Deoxycytidine; Docetaxel; Drug Resistance, Neoplasm; Drug Synergism; Equilibrative Nucleoside Transporter 1; Gemcitabine; Gene Expression Regulation, Neoplastic; HCT116 Cells; HT29 Cells; Humans; Inhibitory Concentration 50; Molecular Structure; Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Taxoids | 2007 |
Inhibition of in vitro lymphocyte transformation during chemotherapy in man.
Topics: Anemia, Hemolytic; Culture Techniques; Cyclophosphamide; Cytarabine; Humans; Immune Tolerance; Lectins; Leukemia; Lymphocytes; Mercaptopurine; Methotrexate; Neoplasms; Prednisolone; Smallpox Vaccine; Uveitis; Vincristine | 1967 |
Drug resistance in cancer.
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antineoplastic Agents; Azacitidine; Cisplatin; Cytarabine; Drug Resistance; Fluorouracil; Humans; Methotrexate; Neoplasms | 1984 |
[Experimental research to clinical application of interferons].
Topics: Animals; Bleomycin; Cytarabine; Drug Therapy, Combination; Humans; Interferon Inducers; Interferon Type I; Interferon-gamma; Interferons; Leukemia, Experimental; Melanoma; Mice; Mitomycin; Mitomycins; Neoplasms; Neoplasms, Experimental | 1984 |
Renal complications of cytotoxic therapy.
Topics: Animals; Antineoplastic Agents; Asparaginase; Cisplatin; Cyclophosphamide; Cytarabine; Dogs; Fluorouracil; Humans; Kidney Diseases; Methotrexate; Mitomycins; Neoplasms; Nitrosourea Compounds; Plicamycin; Procarbazine; Streptozocin; Syndrome | 1983 |
Higher leukocyte nadirs with lithium carbonate after chemotherapy.
Topics: Adolescent; Adult; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Female; Humans; Hydroxyurea; Leukocyte Count; Lithium; Male; Nasopharyngeal Neoplasms; Neoplasms; Neuroblastoma; Papaverine; Rhabdomyosarcoma; Sarcoma, Ewing; Teratoma; Trifluridine; Vincristine; Wilms Tumor | 1980 |
Biochemical and biophysical approaches to improving the anticancer effectiveness of Ara-adenine.
Topics: Adenosine Deaminase Inhibitors; Animals; Antineoplastic Agents; Cytarabine; Deoxyadenine Nucleotides; Deoxycytidine Kinase; Homocysteine; Humans; Isoenzymes; Neoplasms; Nucleotides, Cyclic; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor); Protein Conformation; Vidarabine | 1982 |
Phase I evaluation of 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine in immunosuppressed patients with herpesvirus infection.
Topics: Antiviral Agents; Cytarabine; Drug Evaluation; Hematopoiesis; Herpesviridae Infections; Humans; Immunosuppression Therapy; Neoplasms | 1983 |
Practical applications of the SCE studies for guiding and improving chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cells, Cultured; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Drug Synergism; Humans; Lymphocytes; Neoplasms; Sister Chromatid Exchange; Xanthines | 1984 |
The use of human cancer cell lines as a primary screening system for antineoplastic compounds.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line; Cell Survival; Colonic Neoplasms; Cytarabine; Drug Evaluation, Preclinical; Drug Resistance; Female; Fluorouracil; Humans; Leukemia; Methotrexate; Neoplasms | 1984 |
Phase I clinical evaluation of cytarabine and cisplatin in patients with advanced cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asthenia; Bone Marrow Diseases; Cisplatin; Cytarabine; Drug Evaluation; Female; Humans; Kidney Diseases; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasms; Platelet Count | 1984 |
Pharmacologic and clinical studies of N4-behenoyl-1-beta-D-arabinofuranosylcytosine.
Topics: Animals; Bone Marrow; Cytarabine; Drug Evaluation; Female; Haplorhini; Humans; Leukemia; Macaca; Male; Middle Aged; Neoplasms; Remission, Spontaneous | 1980 |
Relationship of chemotherapy on human cancer xenografts in nude mice to clinical response in donor patient.
Topics: Adult; Animals; Cytarabine; Drug Resistance; Drug Therapy, Combination; Female; Fluorouracil; Humans; Male; Mice; Mice, Nude; Middle Aged; Mitomycins; Neoplasm Transplantation; Neoplasms; Neoplasms, Experimental; Tegafur; Transplantation, Heterologous | 1980 |
Cytotoxicity of 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine and its relationship to deoxycytidine deaminase.
Topics: Antineoplastic Agents; Cytarabine; DCMP Deaminase; Deoxycytidine Kinase; Humans; Neoplasms; Nucleotide Deaminases; Structure-Activity Relationship; Thymidine Kinase | 1983 |
Differences in chemotherapeutic susceptibility of human T-, B-, and non-T-/non-B-lymphocytes in culture.
Topics: Asparaginase; Asparagine; B-Lymphocytes; Cell Line; Cytarabine; Dose-Response Relationship, Drug; Fluorouracil; Humans; Lymphocytes; Neoplasms; T-Lymphocytes | 1980 |
High dose chemotherapy and autologous bone marrow transplantation in acute leukemias, malignant lymphomas and solid tumors. A study of 23 patients.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Female; Freezing; Hematopoiesis; Humans; Leukemia; Leukocyte Count; Lomustine; Lymphoma; Male; Middle Aged; Neoplasms; Platelet Count; Thioguanine; Transplantation, Autologous | 1981 |
Phase I--II study of N4-behenoyl-1-beta-D-arabinofuranosylcytosine.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Cytarabine; Drug Evaluation; Female; Humans; Leukemia; Male; Middle Aged; Neoplasms | 1981 |
[Inhibitors of bone marrow stem cells proliferation. Possible applications during chemotherapy (author's transl)].
Topics: Animals; Cell Division; Cytarabine; Female; Growth Inhibitors; Hematopoietic Stem Cells; Humans; Mice; Mice, Inbred BALB C; Neoplasms | 1981 |
Modeling to determine dose dependence of drug and cell kinetic parameters.
Topics: Animals; Cell Cycle; Cytarabine; DNA; Dose-Response Relationship, Drug; Drug Therapy; Intestine, Small; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Models, Biological; Neoplasms; Pharmaceutical Preparations; Pharmacology | 1980 |
Comparative genotoxicity of 2,3'-O-cyclocytidine, beta-xylocytidine and 1-beta-D-arabinofuranosylcytosine in human tumor cell lines.
Topics: Ancitabine; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cell Survival; Child; Cytarabine; Cytidine; DNA Damage; DNA Repair; DNA Replication; DNA, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Leukemia; Neoplasms; Tumor Cells, Cultured | 1994 |
Expression of adhesion molecules on CD34+ cells: CD34+ L-selectin+ cells predict a rapid platelet recovery after peripheral blood stem cell transplantation.
Topics: Adult; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone Marrow; Bone Marrow Cells; Carboplatin; Carmustine; Cell Adhesion Molecules; Cell Movement; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Epirubicin; Etoposide; Female; Fluorouracil; Gene Expression; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; L-Selectin; Leukocyte Count; Male; Melphalan; Middle Aged; Neoplasms; Neutrophils; Platelet Count; Podophyllotoxin; Receptors, Very Late Antigen; Thiotepa | 1995 |
Prolonged impairment of hematopoiesis after high-dose therapy followed by autologous bone marrow transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Busulfan; Carmustine; Cell Count; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Female; Follow-Up Studies; Hematopoiesis; Hematopoietic Cell Growth Factors; Humans; Male; Melphalan; Methotrexate; Middle Aged; Mitoxantrone; Multivariate Analysis; Neoplasms; Prognosis; Radiation Injuries; Treatment Outcome; Vincristine; Whole-Body Irradiation | 1995 |
Collection and transplantation of peripheral blood stem cells in very small children weighting 20 kg or less.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Component Removal; Blood Preservation; Body Weight; Bone Marrow Diseases; Carboplatin; Catheterization, Central Venous; Catheters, Indwelling; Child, Preschool; Cisplatin; Colony-Forming Units Assay; Combined Modality Therapy; Contraindications; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Infant; Leukemia; Male; Neoplasms; Platelet Transfusion; Retrospective Studies; Safety | 1995 |
X-ray-induced chromatid damage in cells from Down syndrome and Alzheimer disease patients in relation to DNA repair and cancer proneness.
Topics: Adult; Aged; Alzheimer Disease; Cell Cycle; Chromatids; Cytarabine; DNA Damage; DNA Repair; Down Syndrome; Female; Humans; In Vitro Techniques; Interphase; Male; Middle Aged; Neoplasms; X-Rays | 1993 |
Extended CSF cytarabine exposure following intrathecal administration of DTC 101.
Topics: Adolescent; Adult; Aged; Child; Cytarabine; Delayed-Action Preparations; Female; Humans; Injections, Intraventricular; Injections, Spinal; Male; Meningitis; Middle Aged; Neoplasms | 1993 |
Prolactinemia in adolescent males surviving malignancies in childhood: impaired dating activity.
Topics: Adolescent; Adolescent Behavior; Adult; Cisplatin; Cytarabine; Humans; Hyperprolactinemia; Male; Multivariate Analysis; Neoplasms; Prolactin; Radiotherapy; Sexual Behavior; Sexual Dysfunctions, Psychological | 1993 |
[Pharmacodynamics and action mechanism of antitumor agents].
Topics: Antineoplastic Agents; Blood Transfusion; Cytarabine; DNA Damage; DNA Repair; Humans; Leukemia; Neoplasms | 1993 |
Cytosine arabinoside increases the binding of 125I-labelled epidermal growth factor and 125I-transferrin and enhances the in vitro targeting of human tumour cells with anti-(growth factor receptor) mAb.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Cell Division; Cytarabine; Dose-Response Relationship, Drug; Epidermal Growth Factor; ErbB Receptors; Humans; Immunotherapy; Iodine Radioisotopes; KB Cells; Lung Neoplasms; Neoplasms; Radioimmunoassay; Receptors, Cell Surface; Receptors, Transferrin; Time Factors; Transferrin; Tumor Cells, Cultured; Up-Regulation | 1993 |
[Design of a new antitumor nucleoside CNDAC, against solid tumors].
Topics: Antineoplastic Agents; Cytarabine; DNA Damage; DNA Polymerase II; DNA, Neoplasm; Drug Design; Drug Screening Assays, Antitumor; Humans; Neoplasms | 1996 |
Improved priming for mobilization of and optimal timing for harvest of peripheral blood stem cells.
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cells; Blood Transfusion, Autologous; Bone Marrow; Carmustine; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Drug Synergism; Epirubicin; Etoposide; Female; Filgrastim; Fluorouracil; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cells; Humans; Injections, Subcutaneous; Leukapheresis; Leukocyte Count; Male; Melphalan; Middle Aged; Neoplasms; Recombinant Proteins | 1996 |
Inhibition of cytarabine-induced MDR1 (P-glycoprotein) gene activation in human tumor cells by fatty acid-polyethylene glycol-fatty acid diesters, novel inhibitors of P-glycoprotein function.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytarabine; Doxorubicin; Fatty Acids; Gene Expression Regulation, Neoplastic; Genes, MDR; Humans; Neoplasms; Polyethylene Glycols; Surface-Active Agents; Transcriptional Activation; Tumor Cells, Cultured | 1996 |
High-dose cytarabine dose modification reduces the incidence of neurotoxicity in patients with renal insufficiency.
Topics: Adult; Antimetabolites, Antineoplastic; Cytarabine; Drug Administration Schedule; Female; Humans; Incidence; Male; Middle Aged; Neoplasms; Nervous System Diseases; Renal Insufficiency; Retrospective Studies; Risk Factors | 1997 |
Circulating immature cell counts on the harvest day predict the yields of CD34+ cells collected after granulocyte colony-stimulating factor plus chemotherapy-induced mobilization of peripheral blood stem cell.
Topics: Adolescent; Adult; Aged; Antigens, CD34; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Cytarabine; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Leukapheresis; Leukocyte Count; Male; Middle Aged; Neoplasms | 1997 |
Back-up bone marrow is frequently ineffective in patients with poor peripheral-blood stem-cell mobilization.
Topics: Adolescent; Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Blood Transfusion; Bone Marrow; Carmustine; Combined Modality Therapy; Cryopreservation; Cyclophosphamide; Cytarabine; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Middle Aged; Neoplasms; Podophyllotoxin; Treatment Failure | 1998 |
Enhanced cytotoxic effect of Ara-C by low intensity ultrasound to HL-60 cells.
Topics: Antimetabolites, Antineoplastic; Cell Death; Cytarabine; HL-60 Cells; Humans; Leukemia; Neoplasms; Ultrasonic Therapy | 2000 |
Intrathecal cytarabine and bone marrow suppression.
Topics: Agranulocytosis; Antimetabolites, Antineoplastic; Bone Marrow; Cytarabine; Delayed-Action Preparations; Humans; Injections, Spinal; Meningitis; Neoplasms | 2000 |
In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents.
Topics: Antineoplastic Agents; Apoptosis; Benzamides; Cytarabine; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Inhibitors; Fusion Proteins, bcr-abl; Harringtonines; Homoharringtonine; Humans; Hydroxyurea; Imatinib Mesylate; Interferon-alpha; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Microbial Sensitivity Tests; Neoplasm Proteins; Neoplasms; Piperazines; Pyrimidines; Tumor Cells, Cultured; Vincristine | 2001 |
Bystander effects of nucleoside analogs phosphorylated in the cytosol or mitochondria.
Topics: Animals; CHO Cells; Cricetinae; Cytarabine; Cytosol; Deoxycytidine; Deoxycytidine Kinase; Gemcitabine; Genetic Therapy; Mitochondria; Neoplasms; Nucleosides; Phosphorylation | 2001 |
Anticancer drug delivery systems: N4-acyl poly(ethyleneglycol) prodrugs of ara-C. I. Efficacy in solid tumors.
Topics: Animals; Antimetabolites, Antineoplastic; Cytarabine; Drug Delivery Systems; Drug Evaluation, Preclinical; Female; Humans; Leukemia P388; Mice; Mice, Nude; Neoplasms; Polyethylene Glycols; Prodrugs; Solvents; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2002 |
Autologous peripheral blood progenitor cell transplantation with <2 x 10(6) CD34(+)/kg: an analysis of variables concerning mobilisation and engraftment.
Topics: Adolescent; Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Caspase 14; Caspases; Cerebral Hemorrhage; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Erythropoietin; Etoposide; Female; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Infections; Leukapheresis; Life Tables; Male; Middle Aged; Neoplasms; Proportional Hazards Models; Transplantation Conditioning; Transplantation, Autologous | 2000 |
Human cytidine deaminase as an ex vivo drug selectable marker in gene-modified primary bone marrow stromal cells.
Topics: Animals; Antimetabolites, Antineoplastic; Biomarkers; Bone Marrow Cells; Cell Separation; Cytarabine; Cytidine Deaminase; Drug Resistance; Female; Genetic Therapy; Genetic Vectors; Green Fluorescent Proteins; Humans; Luminescent Proteins; Mice; Mice, Inbred C57BL; Neoplasms; Retroviridae; Stromal Cells; Transduction, Genetic; Tumor Cells, Cultured | 2002 |
The clinical pharmacology of antineoplastic agents (second of two parts).
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Azacitidine; Bleomycin; Carmustine; Cell Nucleus; Chemical Phenomena; Chemistry; Cyclohexanes; Cyclophosphamide; Cytarabine; DNA, Neoplasm; Doxorubicin; Humans; Neoplasms; Nitrosourea Compounds | 1975 |
Flow microfluorometric patterns of human bone marrow and tumor cells in response to cancer chemotherapy.
Topics: Antineoplastic Agents; Bone Marrow Cells; Cell Division; Cytarabine; Ethidium; Fluorometry; Humans; Leucovorin; Leukemia, Lymphoid; Melanoma; Methotrexate; Neoplasms; Staining and Labeling | 1976 |
Clinical pharmacology of anticancer drugs.
Topics: Animals; Antineoplastic Agents; Azacitidine; Bleomycin; Cyclophosphamide; Cytarabine; Dacarbazine; Daunorubicin; Doxorubicin; Female; Fluorouracil; Heart; Humans; Leucovorin; Lung; Male; Methotrexate; Neoplasms; Nitrosourea Compounds; Procarbazine; Triazenes; Vinblastine; Vincristine | 1977 |
Oxygen content determined by acrylamide polymerization: screening of anticancer agents, generation of oxyhemoglobin dissociation curves, and potential applications.
Topics: Acrylamides; Adult; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Cell Line; Cycloheximide; Cytarabine; Dactinomycin; Drug Evaluation, Preclinical; Humans; Neoplasms; Oxygen; Oxygen Consumption; Oxyhemoglobins; Polymers; Rats | 1979 |
Evaluation of cyclocytidine in children with advanced acute leukemia and solid tumors.
Topics: Adolescent; Ancitabine; Child; Child, Preschool; Cytarabine; Drug Evaluation; Humans; Infant; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Neoplasms | 1979 |
[Specificity of antitumoral substances].
Topics: Antineoplastic Agents; Bleomycin; Cytarabine; DNA, Neoplasm; Fluorouracil; Neoplasms | 1979 |
Phase I study of 5-fluorodeoxyuridine plus cytosine arabinoside infusions in patients with solid tumors.
Topics: Adolescent; Adult; Aged; Breast Neoplasms; Cytarabine; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Female; Floxuridine; Head and Neck Neoplasms; Humans; Infusions, Parenteral; Male; Malignant Carcinoid Syndrome; Middle Aged; Neoplasms | 1979 |
Clinical and pharmacologic studies with adriamycin-DNA complex in children with malignant disease.
Topics: Child; Cytarabine; DNA; Doxorubicin; Evaluation Studies as Topic; Fibroblasts; Humans; Leukemia, Myeloid, Acute; Neoplasms | 1979 |
[High dose combination chemotherapy with and without autologous bone marrow transplantation in patients with solid tumors and acute leukemias. Kinetics of recovery of peripheral bloods cells (author's transl)].
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Marrow Transplantation; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Female; Hematopoiesis; Humans; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Lomustine; Male; Middle Aged; Neoplasms; Remission, Spontaneous; Thioguanine; Transplantation, Autologous | 1978 |
Ara-C metabolism: implications for drug resistance and drug interactions.
Topics: 3-Deazauridine; Animals; Cytarabine; Cytidine Deaminase; Drug Interactions; Drug Resistance; Humans; Mice; Neoplasms; Tetrahydrouridine | 1979 |
[Cytarabine effectiveness in the prevention and treatment of viral infections in children with neoplastic diseases].
Topics: Chickenpox; Child; Child, Preschool; Cytarabine; Humans; Infant; Neoplasms | 1979 |
The use of cell kinetics in the development of drug combinations.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Division; Cell Separation; Cell Survival; Cytarabine; DNA, Neoplasm; Drug Administration Schedule; Drug Therapy, Combination; Humans; Kinetics; Leukemia; Models, Biological; Multiple Myeloma; Neoplasms | 1979 |
Action of cytosine arabinoside on human tumor cells isolated from malignant effusions: in vitro phosphorylation and inhibition of DNA synthesis.
Topics: Ascites; Cytarabine; DNA, Neoplasm; Drug Resistance; Humans; In Vitro Techniques; Neoplasms; Phosphorylation; Pleural Effusion | 1979 |
A quantitative approach to the design of antitumor drug dosage schedule via cell cycle kinetics and systems theory.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Survival; Cytarabine; DNA, Neoplasm; Drug Administration Schedule; Kinetics; Leukemia, Experimental; Models, Biological; Models, Chemical; Neoplasms | 1977 |
Tetrahydrouridine: Physiologic disposition and effect upon deamination of cytosine arabinoside in man.
Topics: Administration, Oral; Biological Availability; Cytarabine; Cytidine Deaminase; Deamination; Dose-Response Relationship, Drug; Drug Therapy, Combination; Half-Life; Humans; Injections, Intravenous; Neoplasms; Tetrahydrouridine; Uridine | 1977 |
Learned taste aversions in children receiving chemotherapy.
Topics: Adolescent; Anorexia; Antineoplastic Agents; Avoidance Learning; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Digestive System; Doxorubicin; Feeding Behavior; Humans; Neoplasms; Taste; Vincristine | 1978 |
[Virus infections during immunosuppression (author's transl)].
Topics: Adrenal Cortex Hormones; Antibodies; Antilymphocyte Serum; Child; Cyclophosphamide; Cytarabine; Humans; Immunity; Immunity, Cellular; Immunosuppression Therapy; Immunosuppressive Agents; Interferons; Lymphocytes; Neoplasms; Transplantation, Homologous; Virus Diseases; Viruses | 1976 |
Nuclear DNA polymerases of human carcinomas.
Topics: Animals; Breast Neoplasms; Cecal Neoplasms; Cecum; Cell Nucleus; Cytarabine; DNA-Directed DNA Polymerase; DNA, Neoplasm; Humans; Isoenzymes; Liver; Liver Regeneration; Lung; Lung Neoplasms; Neoplasms; Novobiocin; Nucleic Acid Synthesis Inhibitors; Rats | 1977 |
Pharmacology of 5'-esters of 1-beta-D-arabinofuranosylcytosine.
Topics: Animals; Cytarabine; Female; Humans; Injections, Intraperitoneal; Injections, Subcutaneous; Leukemia L1210; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasms; Swine | 1977 |
Continuous drug delivery methods reflect progress in therapy for chronic diseases.
Topics: Aged; Chronic Disease; Cytarabine; Dosage Forms; Drug Implants; Glaucoma; Humans; Injections, Intravenous; Leukemia; Levodopa; Neoplasms; Parkinson Disease; Pilocarpine; Research | 1977 |
[Clinical problems of optimum bioavailability, in particular in cytostatic therapy (author's transl)].
Topics: Animals; Antineoplastic Agents; Biological Availability; Biopharmaceutics; Cytarabine; Daunorubicin; DNA; DNA Nucleotidyltransferases; DNA Replication; Dose-Response Relationship, Drug; Doxorubicin; Half-Life; Humans; Infusions, Parenteral; Kinetics; Mice; Mitosis; Models, Biological; Neoplasms; Rats; RNA; Sarcoma 180 | 1976 |
Clinical studies of beta-thioguanine deoxyriboside alone and in combination with arabinosyl cytosine.
Topics: Acute Disease; Adolescent; Adult; Aged; Child; Child, Preschool; Cytarabine; Deoxyguanosine; Deoxyribonucleosides; Drug Therapy, Combination; Female; Guanosine; Humans; Leukemia; Leukopenia; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Remission, Spontaneous; Thioguanine; Thionucleosides; Thrombocytopenia; Time Factors | 1976 |
The principles and methods of cell synchronization in cancer chemotherapy.
Topics: Animals; Cell Division; Cell Line; Colchicine; Computers; Cytarabine; DNA Replication; Esophagus; Humans; Intestine, Small; Kinetics; Lasers; Mathematics; Mice; Mitosis; Models, Biological; Neoplasm Metastasis; Neoplasms; Neoplasms, Experimental; Organ Specificity; Thymidine; Time Factors | 1976 |
Correlation of response to 1-beta-D-arabinofuranosyl cytosine and metabolism of drug by tumor.
Topics: Cytarabine; Cytosine Nucleotides; Deamination; Female; Hemangiopericytoma; Humans; Leukemia; Leukemia, Myeloid; Melanoma; Middle Aged; Neoplasms; Neoplastic Cells, Circulating; Oxidative Phosphorylation; Splenic Neoplasms | 1976 |
Systemic chemotherapy of advanced head and neck malignancies.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Squamous Cell; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Therapy, Combination; Evaluation Studies as Topic; Fluorouracil; Head; Head and Neck Neoplasms; Humans; Imidazoles; Melanoma; Methotrexate; Neoplasms; Nitrosourea Compounds; Retrospective Studies; Sarcoma; Triazenes; Vincristine | 1975 |
Growth kinetics of solid tumors. Implications for chemotherapy.
Topics: Acute Disease; Adenocarcinoma; Animals; Antineoplastic Agents; Cell Division; Colonic Neoplasms; Culture Techniques; Cytarabine; DNA; Humans; Kinetics; Leukemia; Meiosis; Melanoma; Mitosis; Neoplasms; Neoplasms, Experimental; Rats; Thymidine; Tritium; Vinblastine | 1975 |
Clincal pharmacology of O2,2'-cyclocytidine.
Topics: Administration, Oral; Anhydrides; Antineoplastic Agents; Cytarabine; Deamination; Half-Life; Humans; Hydrolysis; Injections, Intramuscular; Injections, Intravenous; Injections, Spinal; Injections, Subcutaneous; Leukemia; Neoplasms; Time Factors | 1975 |
Oxygen consumption by acrylamide polymerization: a method for rapid screening of anticancer agents.
Topics: Acrylamides; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Cell Survival; Cells, Cultured; Cycloheximide; Cytarabine; Dactinomycin; Depression, Chemical; Drug Evaluation, Preclinical; Neoplasms; Oxygen Consumption; Polymers; Rats | 1975 |
Clinical studies on streptococcal preparation (OK-432) combined with mitomycin-C, 5-FU and cytosine arabinoside in advanced cancer patients.
Topics: Antibiotics, Antineoplastic; Cytarabine; Drug Therapy, Combination; Humans; Mitomycins; Neoplasms; Streptococcus | 1975 |
A discrepancy between the instantaneous and the overall collection efficiency of the Fenwal CS3000 for peripheral blood stem cell apheresis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Blood Cells; Blood Component Removal; Blood Transfusion, Autologous; Bone Marrow Diseases; Cyclophosphamide; Cytarabine; Daunorubicin; Evaluation Studies as Topic; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Neoplasms; Thioguanine | 1992 |
Experience with peripheral blood stem cell collection for autografts in children with active cancer.
Topics: Adolescent; Blood Cells; Blood Component Removal; Blood Transfusion, Autologous; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Female; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Infant; Male; Neoplasms; Safety; Transplantation, Autologous | 1992 |
Relations between the penetration, binding and average concentration of cytostatic drugs in human tumour spheroids.
Topics: Antineoplastic Agents; Autoradiography; Carbon Radioisotopes; Cell Line; Centrifugation; Cytarabine; Dactinomycin; Daunorubicin; Doxorubicin; Humans; Neoplasms; Scintillation Counting; Time Factors; Tritium; Tumor Cells, Cultured | 1992 |
Radiation-induced chromatid aberrations in Cockayne syndrome and xeroderma pigmentosum group C fibroblasts in relation to cancer predisposition.
Topics: Causality; Cells, Cultured; Chromatids; Chromosome Aberrations; Cockayne Syndrome; Cytarabine; DNA Repair; Humans; In Vitro Techniques; Neoplasms; X-Rays; Xeroderma Pigmentosum | 1991 |
Aberrant DNA topoisomerase II activity, radioresistance and inherited susceptibility to cancer.
Topics: Amsacrine; Ataxia Telangiectasia; Cell Line; Cell Nucleus; Cell Transformation, Neoplastic; Cytarabine; Cytoplasm; DNA Repair; DNA Topoisomerases, Type II; DNA, Circular; DNA, Superhelical; Female; Fibroblasts; Gene Expression; Genetic Predisposition to Disease; Humans; Male; Neoplasms; Oncogenes; Radiation Tolerance; Teniposide; Topoisomerase II Inhibitors | 1991 |
Antitumor activity of 2'-deoxy-2'-methylidenecytidine, a new 2'-deoxycytidine derivative.
Topics: Animals; Cytarabine; Deoxycytidine; Drug Administration Schedule; Drug Screening Assays, Antitumor; Female; Humans; Leukemia P388; Male; Melanoma; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasms; Tumor Cells, Cultured | 1991 |
Cisplatin preceded by concurrent cytarabine and hydroxyurea: a pilot study based on an in vitro model.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; DNA Repair; Drug Administration Schedule; Drug Evaluation; Female; Humans; Hydroxyurea; Male; Middle Aged; Neoplasms; Thrombocytopenia | 1990 |
Septicemia in pediatric oncology patients: the significance of viridans streptococcal infections.
Topics: Adolescent; Adult; Agranulocytosis; Child; Child, Preschool; Cytarabine; Female; Humans; Infant; Lung Diseases; Male; Neoplasms; Retrospective Studies; Risk Factors; Sepsis; Streptococcal Infections | 1990 |
3-Deazauridine (NSC 126849): an interesting modulator of biochemical response.
Topics: 3-Deazauridine; Acute Disease; Animals; Antineoplastic Agents; Azacitidine; Cytarabine; Decitabine; Drug Evaluation; Drug Synergism; Galactosamine; Humans; Kinetics; Leukemia; Neoplasms; Thymidine; Uridine | 1986 |
Arabinofuranosyl-5-azacytosine: activity against human tumors in athymic mice.
Topics: Animals; Antineoplastic Agents; Azacitidine; Cell Transformation, Neoplastic; Cytarabine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Stereoisomerism; Time Factors; Transplantation, Heterologous; Tumor Cells, Cultured | 1989 |
Leukaemia Research Fund international research symposium on cytotoxic drug resistance in leukemia and other malignancies.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Biological Transport; Cisplatin; Congresses as Topic; Cytarabine; DNA; Drug Resistance; Gene Amplification; Glutathione Transferase; Humans; Leukemia; Leukemia, Myeloid, Acute; Neoplasms; Nucleosides; Oxygen; Phenotype; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1989 |
[Continuous venous infusion in cancer chemotherapy].
Topics: Bleomycin; Bone Marrow; Breast Neoplasms; Cytarabine; Doxorubicin; Drug Administration Schedule; Fluorouracil; Heart; Humans; Infusions, Parenteral; Lung Neoplasms; Neoplasms | 1985 |
Mitoxantrone and high-dose ara-C in refractory malignancies: a phase I trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Drug Evaluation; Humans; Middle Aged; Mitoxantrone; Neoplasms | 1989 |
New cytarabine analogs.
Topics: Animals; Biological Transport; Cytarabine; Drug Evaluation, Preclinical; Drug Resistance; Humans; Mice; Molecular Structure; Neoplasms; Neoplasms, Experimental | 1989 |
In vitro sensitivity of various human tumors to 1-beta-D-arabinofuranosylcytosine and N4-behenoyl-1-beta-D-arabinofuranosylcytosine.
Topics: Antineoplastic Agents; Cytarabine; Drug Screening Assays, Antitumor; Humans; Neoplasms; Succinate Dehydrogenase | 1989 |
[Recent advances and trends in cancer chemotherapy using nucleoside analogs].
Topics: Animals; Cell Transformation, Neoplastic; Cytarabine; Floxuridine; Humans; Neoplasms; Nucleosides; Structure-Activity Relationship | 1988 |
Study on the long-term toxic efficacy of cytosine-arabinoside in Sprague-Dawley rats.
Topics: Animals; Body Weight; Colony-Forming Units Assay; Cytarabine; Female; Hematopoietic Stem Cells; Male; Neoplasms; Rats; Rats, Inbred Strains; Time Factors | 1988 |
Heterogeneity of the response to inducers of differentiation and to cytostatics of tumor cell populations.
Topics: Antineoplastic Agents; Cell Differentiation; Cisplatin; Cytarabine; Dacarbazine; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Doxorubicin; Fluorouracil; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Promyelocytic, Acute; Melanoma; Neoplasms; Tetradecanoylphorbol Acetate; Tretinoin; Tumor Cells, Cultured | 1988 |
Few genetic mutations, many cancers, say experts.
Topics: Acute Disease; Child; Cytarabine; Eye Neoplasms; Humans; Leukemia, Myeloid, Acute; Mutation; Neoplasms; Oncogenes; Retinoblastoma; T-Lymphocytes, Cytotoxic | 1986 |
Tissue culture and animal toxicity studies of antineoplaston A5.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line; Culture Techniques; Cytarabine; DNA, Neoplasm; Humans; Lethal Dose 50; Mice; Mice, Inbred ICR; Neoplasms; Peptides | 1987 |
Phase I clinical and pharmacokinetic study of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Agents; Bone Marrow; Cytarabine; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukocyte Count; Male; Middle Aged; Nausea; Neoplasms | 1987 |
Cisplatin and low-dose cytosine arabinoside in advanced cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms | 1987 |
[Drug administration in combination for management of cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Doxorubicin; Drug Administration Schedule; Drug Synergism; Fluorouracil; Humans; Mercaptopurine; Methotrexate; Neoplasms; Nimustine; Nitrosourea Compounds | 1985 |
[High-dose treatment].
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Daunorubicin; Doxorubicin; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Humans; Infusions, Parenteral; Leucovorin; Leukemia; Methotrexate; Neoplasms | 1985 |
[Biochemical modulation in cancer chemotherapy].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Synergism; Fluorouracil; Humans; Leukemia L1210; Methotrexate; Mice; Neoplasms; Nucleosides; Pyrimidine Nucleosides | 1985 |
Response of therapy-associated acute nonlymphocytic leukemia to intensive induction chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Doxorubicin; Female; Humans; Leukemia; Leukemia, Radiation-Induced; Male; Middle Aged; Neoplasms; Prednisone; Prognosis; Thioguanine; Vincristine | 1985 |
Continuous infusion of high-dose 1-beta-D-arabinofuranosylcytosine: a phase I and pharmacological study.
Topics: Adult; Aged; Bone Marrow; Cytarabine; Drug Evaluation; Humans; Middle Aged; Neoplasms; Thrombocytopenia | 1985 |
Phase I trials of high-dose cytosine arabinoside (HDara-C) and HDara-C plus cisplatin in patients with advanced malignancies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dose-Response Relationship, Drug; Drug Evaluation; Fatigue; Humans; Kidney Diseases; Leukopenia; Middle Aged; Neoplasms; Thrombocytopenia | 1985 |
Cytarabine-cis-platin interactions in patients with advanced cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asthenia; Carcinoma, Bronchogenic; Cisplatin; Cytarabine; Dose-Response Relationship, Drug; Drug Evaluation; Female; Gastrointestinal Diseases; Humans; Kidney Diseases; Leukopenia; Lung Neoplasms; Lymphoma; Male; Middle Aged; Neoplasms; Neutropenia; Thrombocytopenia | 1985 |
Chemotherapeutic suppression of immune enhancement: a primary determinant of successful cancer therapy.
Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents; B-Lymphocytes; Cell Survival; Child; Cyclophosphamide; Cytarabine; Disease Models, Animal; Graft Rejection; Graft vs Host Reaction; Humans; Immunity; Immunity, Cellular; Immunosuppression Therapy; Immunosuppressive Agents; Kinetics; Lymph Nodes; Neoplasms; Spleen; T-Lymphocytes; Transplantation Immunology | 1973 |
[Selective tumour chemotherapy using oncobiograms (author's transl)].
Topics: Animals; Antineoplastic Agents; Bleomycin; Cricetinae; Culture Techniques; Cytarabine; Dactinomycin; Daunorubicin; Doxorubicin; Drug Evaluation; Drug Resistance; Fluorouracil; Humans; Methods; Methotrexate; Neoplasm Transplantation; Neoplasms; Neoplasms, Experimental; Procarbazine; Radioisotopes; Rats; Scintillation Counting; Thymidine; Triaziquone; Uridine | 1974 |
Chemotherapy in recurrent heat and neck cancer.
Topics: Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Fluorouracil; Head; Head and Neck Neoplasms; Humans; Hydroxyurea; Injections, Intra-Arterial; Injections, Intramuscular; Methotrexate; Neoplasm Recurrence, Local; Neoplasms; Vinblastine; Vincristine | 1974 |
In vitro methods to complement in vivo approaches utilizing combinations of chemotherapy and immunotherapy.
Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents; Bleomycin; Carmustine; Cells, Cultured; Chickens; Clone Cells; Concanavalin A; Culture Techniques; Cytarabine; Cytological Techniques; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Humans; Immunity, Cellular; Immunotherapy; Lectins; Lipopolysaccharides; Lymphocytes; Melanoma; Mice; Mitosis; Neoplasms; Neoplasms, Experimental; Thymidine | 1974 |
[The effects of cytostatic agents on short-term cultures (3H-uridine incorporation) and tissue cultures (cell counts) from human tumors (author's transl)].
Topics: Antineoplastic Agents; Bleomycin; Cell Count; Cell Transformation, Neoplastic; Cells, Cultured; Cytarabine; Dactinomycin; Daunorubicin; Doxorubicin; Drug Evaluation, Preclinical; Female; Fluorouracil; Humans; In Vitro Techniques; Methods; Methotrexate; Neoplasms; Ovarian Neoplasms; Podophyllin; Suspensions; Time Factors; Triaziquone; Tritium; Uridine | 1974 |
The immunosuppressive activity of ara-C (cytarabine) and derivatives.
Topics: Adjuvants, Immunologic; Animals; Antibody Formation; Antilymphocyte Serum; Arthritis; Autoimmune Diseases; Cricetinae; Cytarabine; Dogs; Drug Synergism; Encephalomyelitis, Autoimmune, Experimental; Escherichia coli Infections; Graft Rejection; Graft vs Host Reaction; Guinea Pigs; Humans; Immunosuppression Therapy; Kidney Transplantation; Mice; Neoplasms; Rabbits; Rats; Skin Transplantation; Transplantation, Homologous | 1973 |
Effect of chemotherapeutic agents upon microorganisms isolated from cancer patients.
Topics: Antineoplastic Agents; Cyclophosphamide; Cytarabine; Escherichia coli; Humans; Klebsiella pneumoniae; Methotrexate; Neoplasms; Proteus; Pseudomonas aeruginosa; Serratia marcescens | 1972 |
Pharmacodynamic and pharmacokinetic measurements of antitumor agents.
Topics: Animals; Antineoplastic Agents; Body Surface Area; Cell Division; Cricetinae; Culture Techniques; Cyclophosphamide; Cytarabine; Dogs; Half-Life; Haplorhini; Humans; Kinetics; Leukemia L1210; Leukemia, Myeloid; Methotrexate; Mice; Mice, Inbred Strains; Neoplasms; Rats; Species Specificity; Time Factors | 1974 |
Clinical studies with systemic administration of antimetabolites of pyrimidine nucleosides in viral infections.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Antimetabolites; Cytarabine; Female; Floxuridine; Gangrene; Herpes Zoster; Hodgkin Disease; Humans; Idoxuridine; Infant; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasms; Rhabdomyosarcoma; Smallpox; Vaccination; Vaccinia; Virus Diseases | 1965 |
Nonidentiy of some simian virus 40-induced enzymes with tumor antigen.
Topics: Aminohydrolases; Animals; Antigens; Cell Line; Cell Transformation, Neoplastic; Chromatography, Gel; Complement Fixation Tests; Cricetinae; Culture Techniques; Cytarabine; DNA Nucleotidyltransferases; Enzyme Induction; Haplorhini; Kidney; Ligases; Mice; Neoplasms; Phosphotransferases; Simian virus 40; Tetrahydrofolate Dehydrogenase; Thymidine Kinase | 1967 |
[Herpes simplex virus and its infections].
Topics: Cytarabine; Eczema; Female; Gingivitis; Herpes Simplex; Herpesviridae; Humans; Idoxuridine; Infant, Newborn; Keratitis; Male; Meningoencephalitis; Neoplasms; Oncogenic Viruses; Paronychia; Pregnancy; Pregnancy Complications, Infectious; Simplexvirus; Stomatitis; Uterine Cervicitis; Vulvovaginitis | 1973 |
Herpes zoster in children with cancer.
Topics: Adolescent; Bacterial Infections; Child; Child, Preschool; Cobalt Isotopes; Cytarabine; Herpes Zoster; Herpesvirus 3, Human; Hodgkin Disease; Humans; Idoxuridine; Immunoglobulins; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Neoplasms; Peptide Hydrolases; Recurrence; Remission, Spontaneous; Seasons; Splenectomy | 1973 |
Combination therapy: some concepts and results.
Topics: Animals; Antineoplastic Agents; Child; Cyclohexanes; Cyclophosphamide; Cytarabine; Dactinomycin; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Humans; Imidazoles; Leukemia L1210; Lung Neoplasms; Melanoma; Mice; Neoplasm Metastasis; Neoplasms; Neoplasms, Experimental; Nitrogen Mustard Compounds; Nitrosourea Compounds; Thioguanine; Triazenes; Wilms Tumor | 1974 |
[Research on optimal dosage schemes in clinical experimentation with antineoplastic agents].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Cytarabine; Daunorubicin; Drug Combinations; Glycosides; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Naphthacenes; Neoplasms | 1972 |
Disappearance after chemotherapy of blocking serum factors as measured in vitro with lymphocytes cytotoxic to tumor cells.
Topics: Adolescent; Carcinoma, Squamous Cell; Cell Line; Chondrosarcoma; Cytarabine; Cytotoxicity Tests, Immunologic; Female; Fibrosarcoma; Humans; Immunity, Cellular; Liposarcoma; Lung Neoplasms; Lymphocytes; Male; Neoplasm Metastasis; Neoplasms; Osteitis Deformans; Osteosarcoma; Rhabdomyosarcoma | 1972 |
Hemorrhagic cystitis and vesicoureteral reflux secondary to cytotoxic therapy for childhood malignancies.
Topics: Child, Preschool; Cyclophosphamide; Cystitis; Cytarabine; Eye Neoplasms; Female; Ganglioneuroma; Hematuria; Humans; Infant; Leukemia, Myeloid, Acute; Male; Neoplasms; Radiography; Retinoblastoma; Stomach Neoplasms; Urinary Bladder; Vesico-Ureteral Reflux | 1973 |
[A new approach to chemotherapeutic combinations in the treatment of solid tumors: trail synchronization, recruitement].
Topics: Antineoplastic Agents; Cyclophosphamide; Cytarabine; Doxorubicin; Humans; Kinetics; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukocyte Count; Methotrexate; Mitosis; Neoplasms; Vincristine | 1973 |
The therapy of acute granulocytic leukemia in patients more than fifty years old.
Topics: Age Factors; Aged; Antineoplastic Agents; Connecticut; Cytarabine; Drug Combinations; Hospitals, Community; Hospitals, Special; Hospitals, Teaching; Humans; Leukemia, Myeloid, Acute; Middle Aged; Neoplasms; New York City; Prognosis; Remission, Spontaneous; Thioguanine | 1974 |
Pharmacokinetics of 1-beta-D-arabinofuranosylcytosine in humans.
Topics: Adult; Aged; Chromatography; Chromatography, Paper; Cytarabine; Female; Half-Life; Humans; Kinetics; Leukemia, Myeloid; Male; Middle Aged; Neoplasms; Tritium | 1974 |
Blood and neoplastic diseases. Rational approach to the chemotherapy of human malignant disease-II.
Topics: Antineoplastic Agents; Brain Neoplasms; Busulfan; Cell Count; Cell Division; Cytarabine; Diffusion; Drug Tolerance; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukocyte Count; Lymphoma; Methotrexate; Multiple Myeloma; Neoplasms; Vincristine | 1974 |
Cancer chemotherapy: mechanisms of action.
Topics: Alkaloids; Alkylating Agents; Antibiotics, Antineoplastic; Antineoplastic Agents; Binding Sites; Cytarabine; Drug Synergism; Enzyme Therapy; Folic Acid Antagonists; Humans; Hydroxyurea; Leucovorin; Mechlorethamine; Mercaptopurine; Methotrexate; Mitomycins; Neoplasms; Nucleic Acids; Purines; Pyrimidines; Steroids; Thioguanine; Vinblastine; Vincristine | 1973 |
Letter: Cytosine arabinoside for herpes zoster.
Topics: Cytarabine; Herpes Zoster; Herpes Zoster Ophthalmicus; Humans; Neoplasms | 1974 |
Studies on drug resistance. IV. Synthesis and biological activities of 1- -D-arabinofuranosylcytosine 3',5'-cyclic monophosphate and a derivative.
Topics: Animals; Cell Line; Chromatography, Thin Layer; Cytarabine; Cytosine Nucleotides; Drug Resistance; Methods; Neoplasms; Spectrophotometry, Ultraviolet | 1972 |
1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given alone and combined with antimetabolites in the treatment of advanced solid tumors.
Topics: Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Cystadenoma; Cytarabine; Female; Humans; Leukopenia; Lung Neoplasms; Male; Methotrexate; Nausea; Neoplasm Metastasis; Neoplasms; Nitrosourea Compounds; Ovarian Neoplasms; Stomach Neoplasms; Vomiting | 1972 |
Water intoxication in man after cyclophosphamide therapy. Time course and relation to drug activation.
Topics: Adolescent; Adult; Aged; Blood Urea Nitrogen; Body Weight; Creatinine; Cyclophosphamide; Cytarabine; Erythrocytes; Female; Humans; Hyponatremia; Injections, Intravenous; Male; Middle Aged; Neoplasms; Osmolar Concentration; Serum Albumin; Sodium; Time Factors; Urine; Water Intoxication | 1973 |
[Attempt at the prevention of lymphosarcoma penetration into the central nervous system].
Topics: Adolescent; Central Nervous System Diseases; Child; Child, Preschool; Cytarabine; Female; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Metastasis; Neoplasms | 1973 |
The effects of chemotherapy on the morphology of solid tumours.
Topics: Antineoplastic Agents; Cell Division; Cell Nucleus; Cells; Cytarabine; Hydroxyurea; Intestinal Mucosa; Intestine, Small; Methotrexate; Microscopy, Electron; Mitosis; Neoplasms; Phagocytosis; Time Factors; Vinca Alkaloids | 1974 |
[Chemotherapy of cancer. Hints for continuing medical education].
Topics: Antineoplastic Agents; Busulfan; Chlorambucil; Cyclophosphamide; Cytarabine; Daunorubicin; Education, Medical, Continuing; Fluorouracil; Humans; Melphalan; Mercaptopurine; Methotrexate; Neoplasms; Procarbazine; Triaziquone; Vinblastine; Vincristine | 1974 |
Plasma levels of methotrexate in cancer patients as studied by an improved spectrophotofluorometric method.
Topics: Adult; Aged; Chromatography, Ion Exchange; Creatinine; Cytarabine; Diatrizoate; Female; Folic Acid; Heparin; Humans; Hydrogen-Ion Concentration; Male; Methods; Methotrexate; Middle Aged; Neoplasms; Oxidation-Reduction; Potassium Permanganate; Spectrometry, Fluorescence; Time Factors; Triamterene; Tritium; Tryptophan; Tungsten | 1974 |
Immunosuppressive effects of cytosine arabinoside and methotrexate in man.
Topics: Adult; Aged; Antibody Formation; Cytarabine; Escherichia coli; Female; Humans; Immunosuppressive Agents; Lymphocytes; Male; Methotrexate; Middle Aged; Neoplasms; Tetanus Toxoid | 1969 |
Sponges, cancer chemotherapy, and cellular aging.
Topics: Bacteriological Techniques; Cytarabine; DNA; Escherichia coli; Neoplasms; Nucleosides; Phosphates; Porifera; Protein Biosynthesis; Ribose; RNA; Uracil | 1963 |
Serologic surveys of human cancer patients for antibody to adenovirus T antigens.
Topics: Adenoviridae; Animals; Antibodies; Antigens; Cell Line; Complement Fixation Tests; Cricetinae; Cytarabine; Cytopathogenic Effect, Viral; Fluorescent Antibody Technique; Haplorhini; Humans; Kidney; Neoplasms; Oncogenic Viruses | 1970 |
Cell proliferation and the differential response of normal and malignant tissues. Silvanus Thompson Memorial Lecture.
Topics: Animals; Blood Vessels; Busulfan; Cell Survival; Cyclophosphamide; Cytarabine; Diffusion; Epithelial Cells; Epithelium; Fibrosarcoma; Hematopoietic Stem Cells; Intestine, Small; Leukemia L1210; Leukemia, Experimental; Methotrexate; Mice; Mitosis; Necrosis; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Oxygen; Radiation Effects; Rats | 1972 |
Combined therapy with cytosine arabinoside (NSC-63878) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for advanced solid tumors.
Topics: Adult; Alkylating Agents; Blood Cell Count; Carmustine; Cytarabine; Drug Combinations; Humans; Male; Neoplasms; Nitroso Compounds; Nitrosourea Compounds; Time Factors; Urea | 1972 |
[Combined application of drugs in cancer chemotherapy with special reference to the combination of mitomycin C, 5-fluorouracil, and cytosine arabinoside].
Topics: Cytarabine; Female; Fluorouracil; Humans; Lung Neoplasms; Lymphatic Metastasis; Mitomycins; Neoplasms; Rectal Neoplasms; Stomach Neoplasms; Uterine Neoplasms | 1972 |
[Clinical evaluation of antineoplastic agents].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Cytarabine; Humans; Neoplasms; Nitrosourea Compounds; Pipobroman | 1972 |
Multiple drug therapy for disseminated malignant tumours.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Child; Cyclophosphamide; Cytarabine; Dactinomycin; Drug Synergism; Female; Fluorouracil; Humans; Leukocyte Count; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasms; Remission, Spontaneous; Urinary Bladder Neoplasms; Vincristine | 1971 |
Cytogenetic and morphologie abnormalities in human bone marrow cells during cytosine arabinoside therapy.
Topics: Bone Marrow; Bone Marrow Cells; Chromosomes; Cytarabine; Humans; Leukemia, Myeloid; Neoplasms | 1966 |
Comparative sensitivity to various antimetabolites of several established cell lines derived from the buffy coat of normal humans and patients with neoplastic diseases.
Topics: Antimetabolites; Blood Cells; Cell Line; Culture Techniques; Cytarabine; Fluorouracil; Humans; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Mercaptopurine; Methotrexate; Mitosis; Neoplasms | 1969 |
Advances in the chemotherapy of malignant disease.
Topics: Antibiotics, Antineoplastic; Asparaginase; Cytarabine; Drug Combinations; Hodgkin Disease; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Medication Systems, Hospital; Neoplasms | 1971 |
New approaches in administration of anticancer drugs.
Topics: Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Cytarabine; Female; Fluorouracil; Humans; Lung Neoplasms; Mercaptopurine; Methotrexate; Neoplasms; Prognosis; Time Factors | 1969 |
A clinical evaluation of a prolonged schedule of cytosine arabinoside (NSC63878).
Topics: Adenocarcinoma; Blood Cells; Bone Marrow; Breast Neoplasms; Carcinoma; Colonic Neoplasms; Cytarabine; Female; Hematopoiesis; Humans; Leiomyosarcoma; Leukocyte Count; Liver; Lung Neoplasms; Melanoma; Neoplasm Metastasis; Neoplasms; Pancreatic Neoplasms; Sarcoma; Ureteral Neoplasms; Urethral Neoplasms | 1970 |
1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given concomitantly with cytosine arabinoside (NSC-63878) in the treatment of cancer.
Topics: Adult; Aged; Antineoplastic Agents; Cytarabine; Female; Humans; Leukemia; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Nitroso Compounds; Nitrosourea Compounds; Urea | 1970 |